Agency of the United States Department of Health and Human Services
POPULARITY
Categories
357 episodes with fda
281 episodes with fda
183 episodes with fda
247 episodes with fda
229 episodes with fda
126 episodes with fda
183 episodes with fda
112 episodes with fda
147 episodes with fda
150 episodes with fda
273 episodes with fda
183 episodes with fda
178 episodes with fda
185 episodes with fda
53 episodes with fda
82 episodes with fda
75 episodes with fda
90 episodes with fda
65 episodes with fda
62 episodes with fda
135 episodes with fda
55 episodes with fda
70 episodes with fda
107 episodes with fda
107 episodes with fda
61 episodes with fda
68 episodes with fda
36 episodes with fda
96 episodes with fda
44 episodes with fda
50 episodes with fda
65 episodes with fda
44 episodes with fda
42 episodes with fda
105 episodes with fda
43 episodes with fda
64 episodes with fda
50 episodes with fda
47 episodes with fda
51 episodes with fda
61 episodes with fda
97 episodes with fda
78 episodes with fda
41 episodes with fda
38 episodes with fda
59 episodes with fda
64 episodes with fda
56 episodes with fda
55 episodes with fda
97 episodes with fda
73 episodes with fda
59 episodes with fda
49 episodes with fda
99 episodes with fda
This week we welcome double board-certified dermatologist AND dermatopathologist, Dr. Aegean Chan to bridge the gap between medical dermatology and your daily skincare routine. Tapping her clinical expertise in medical dermatology, skin cancer and acne, we unwrap Dr. Chan's professional insights on the skin barrier, sun protection, and why she believes we should be wary of "anec-data" especially when it comes to a $400 serum.In this week's episode, we discuss: How truly complex the skin barrier is (as she sees it under a microscope), and why it's the foundation of great skinHoliday break ready! Which sunscreen Dr. Chan personally buys in bulkTruth bombs about Vitamin C! Why Dr. Chan doesn't think this hero ingredient is right for everyoneWhy she *doesn't* think shopping for skincare based on a pH level is a necessary strategyWhat Dr. Chan makes of transdermal patches for skincare – are they the future of youthful skin?Plus: Should we rethink trending, in-office procedures like radiofrequency combined with microneedling per recent FDA guidelines? For any products or links mentioned in this episode, check out our website: https://breakingbeautypodcast.com/episode-recaps/ Get social with us and let us know what you think of the episode! Find us on Instagram, Tiktok,X, Threads. Join our private Facebook group. Or give us a call and leave us a voicemail at 1-844-227-0302. Sign up for our Substack here. Subscribe to our YouTube Channel to watch our episodes! Related episodes like this: Derm Hot Takes! The Real Deal on Those Viral Hypochlorous Acid Skin Sprays, the Most Legit At-Home Skincare Devices and the Unsexy Vitamin C Serum You Need To Know About NowAre You Applying Your Sunscreen the Right Way? Plus Myth-Busting Those Rage-Bait SPF Headlines, Tanning on Trial and More With Board-Certified Dermatologist Dr. Michelle HenryDr. Muneeb Shah aka @DermDoctor On Starter Skincare Routines For Aging Skin, The New Accutane-Alternative For Acne and Should You Mix Your Rx Retinol With Drugstore Moisturizer?? PROMO CODES: When you support our sponsors, you support the creation of Breaking Beauty Podcast! SeedGet ahead of the New Year with a routine that helps you now by going to Seed.com/BEAUTY and use code BEAUTY to get 20% off your first month of Seed's DS-01® Daily Synbiotic.Curology Enjoy our limited-time holiday offer — a personalized prescription FREE with your subscription, all you pay is $5.45 shipping and handling! To claim this offer, go to curology.com/beauty to take Curology's skin quiz! In just a few minutes, you'll share your skin concerns and upload a few photos for a licensed dermatology provider, who will create a custom treatment plan tailored to your unique goals. Restrictions apply. See website for full details and important safety information. *Disclaimer: Unless otherwise stated, all products reviewed are gratis media samples submitted for editorial consideration.* Hosts: Carlene Higgins and Jill Dunn Theme song, used with permission: Cherry Bomb by Saya Produced by Dear Media Studio See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Why the weather could make holiday travel for some a challenge. The FDA approves a new option in the world of weight loss drugs. And, all aboard! A Christmas train bringing joy to the rails from stop to stop. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
A new Intermountain Health study presented at the American Heart Association's 2025 Scientific Sessions found that adults with heart disease who optimized their vitamin D levels cut their risk of another heart attack by 52% Most participants began the trial with low vitamin D levels, showing that deficiency is common in people with cardiovascular disease and silently increases the risk of recurring heart problems More than half of the patients needed over 5,000 IU of vitamin D3 daily — six times the FDA's recommended intake — to reach protective blood levels between 40 and 80 ng/mL Vitamin D acts as a hormone that helps lower inflammation, maintain proper calcium balance, improve blood vessel function, and reduce oxidative stress — all key to preventing heart damage Regular testing, personalized dosing, sunlight exposure, and daily exercise are simple, measurable ways to restore vitamin D, strengthen your heart, and reduce your risk of another cardiac event
The people running our federal health agencies have finally pulled back the curtain, and what they're revealing changes everything we thought we knew about how decisions get made at the highest levels of government. In this groundbreaking conversation, FDA Commissioner Dr. Marty Makary discusses the sweeping reforms transforming America's approach to food safety, drug approvals, and medical transparency under the Make America Healthy Again initiative. What would you change first if you had the power to reform our entire healthcare system? CLICK HERE TO BECOME GARYS VIP!: https://bit.ly/4ai0Xwg Get Dr. Marty Makary's book, “Blind Spots“ here: https://bit.ly/3MIcg9x Connect with Dr. Marty Makary Website: https://bit.ly/48JPxCD YouTube: https://bit.ly/4j2IBUx Instagram: https://bit.ly/4qaIicv TikTok: https://bit.ly/48UlOFK Facebook: https://bit.ly/4pJ9QG4 X.com: https://bit.ly/4pIWGcd Thank you to our partners H2TABS: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4hMNdgg BODYHEALTH: “ULTIMATE20” FOR 20% OFF: http://bit.ly/4e5IjsV BAJA GOLD: "ULTIMATE10" FOR 10% OFF: https://bit.ly/3WSBqUa COLD LIFE: THE ULTIMATE HUMAN PLUNGE: https://bit.ly/4eULUKp WHOOP: JOIN AND GET 1 FREE MONTH!: https://bit.ly/3VQ0nzW AION: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4h6KHAD A-GAME: “ULTIMATE15” FOR 15% OFF: http://bit.ly/4kek1ij PEPTUAL: “TUH10” FOR 10% OFF: https://bit.ly/4mKxgcn CARAWAY: “ULTIMATE” FOR 10% OFF: https://bit.ly/3Q1VmkC HEALF: 10% OFF YOUR ORDER: https://bit.ly/41HJg6S RHO NUTRITION: “ULTIMATE15” FOR 15% OFF: https://bit.ly/44fFza0 GOPUFF: GET YOUR FAVORITE SNACK!: https://bit.ly/4obIFDC GENETIC METHYLATION TEST (UK ONLY): https://bit.ly/48QJJrk GENETIC TEST (USA ONLY): https://bit.ly/3Yg1Uk9 Watch the “Ultimate Human Podcast” every Tuesday & Thursday at 9AM EST: YouTube: https://bit.ly/3RPQYX8 Podcasts: https://bit.ly/3RQftU0 Connect with Gary Brecka Instagram: https://bit.ly/3RPpnFs TikTok: https://bit.ly/4coJ8fo X: https://bit.ly/3Opc8tf Facebook: https://bit.ly/464VA1H LinkedIn: https://bit.ly/4hH7Ri2 Website: https://bit.ly/4eLDbdU Merch: https://bit.ly/4aBpOM1 Newsletter: https://bit.ly/47ejrws Ask Gary: https://bit.ly/3PEAJuG Timestamps 00:00 Intro of Show 03:29 Leading the Food and Drug Administration 07:22 Setting the FDA's Mission and Agenda 12:12 Time to Change the Medical Educational System 17:01 Going through the FDA's Agenda 22:48 Rewriting the Food Dietary Guidelines 27:13 Unveiling the Scientific Data 30:01 The Truth behind Hormone Therapy 37:32 Dr. Marty's Vision for the FDA 39:19 Are Children Over-Vaccinated? 43:21 FDA's Movement on Vaccination 45:48 FDA Belongs to the American People, Not the Big Pharma 46:41 FDA on Peptides, Stem Cells, and Other Unconventional Therapies 48:14 Scientific Data on Gut Microbiome (Addressing Cancer, Diabetes) 1:14:31 FDA's Challenges against Political Bureaucracy 1:17:01 What does it mean to you to be an Ultimate Human? The Ultimate Human with Gary Brecka Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The Content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices
PODCAST LAS NOTICIAS CON CALLE DE 23 DE DICIEMBRE 2025 - Trump hace nueva flota de barcos que se llamarán Trump - FTNovo Nordisk logra FDA apruebe medicamento para rebajar con pastilla diaria siendo la primera en lograrlo - FTCerca de epidemia de influenza A - El Vocero Otra vez irregularidad de subasta en cámaras de escuelas, vuelven a ordenar subasta - Metro Nuevas leyes sobre el cuerpo de la mujer y embarazo, leyes contradictorias unas con otras - El Nuevo Día Más hospitales al borde de la quiebra en 2026 - El Nuevo Día FEMA exige que todo proyecto vuelva a evaluarse si hay cambios de 100 mli dólares retrasando reconstrucción de PR - El Vocero Seguirá gratis el Tren Urbano - Primera Hora Gobierno le da los 40 millones a Bayamón para terminar la PR 5, no va la PR 10 - Primera HoraSube la presión para quedarse con CNN, Warner Bros. Discovery - QzSecretaria de Vivienda dice que hay que agilizar títulos de propiedad, pero pelea con la Junta por expresiones de que no hay plan del gobierno de PR para resolver el problema de Vivienda - El Vocero La Junta saldrá a favorecer a LUMA en contrato advirtiendo que tiene impacto fiscal el pleito legal del gobierno - El Vocero Trump detiene demanda contra la Junta de PR para ver lo que resuelve el Supremo sobre su autoridad de botar gente de la rama ejecutiva - El Vocero Salud dice que nuevas leyes no alteran la decisión de mujeres embarazadas - El Vocero Aguadilla pide que le den ciudadanía a PR, mientras senador federal exige que se tenga que escoger entre ciudadanía de USA u otras, pero no podrían tener las dos - El Vocero Proponen modelo para convertir estadio hasta de 50 mil personas - El Vocero Rivera Schatz empuja proyecto de Juan Oscar Morales para las escoltas - El Nuevo Día JGo descarta conflictos de interés en casos de sus portavoces contratistas - El Nuevo Día Van al Tribunal Supremo para evitar que baje de precio medicamentos como Eliquis - Axios Trump mata las fincas solares que estaban sin construirse, le quita los fondos - NYTLarry Ellison plantea dar de su propio dinero hasta 40 billones para comprar Paramount - WSJ Para una salud completa, MCS Personal Directo te ofrece cubiertasaccesibles para que cuides de tu salud y la de los tuyos con el MCS Alivia, unprograma de medicina integral y alternativa que beneficia a pacientes con múltiplescondiciones crónicas, a través de terapias y servicios de acupuntura, masajeterapéutico, reflexología, entre otras modalidades, que pueden complementar tutratamiento médico tradicional.¡Únete HOY a la familia de MCS!¡Salud que completa tu vida! Llama al 787.945.1259 y oriéntate.Endoso pagado
The S&P 500 closing at a fresh record high, as commodities come along for the ride. If the metal moves in Gold, Silver, and Copper can keep rocking into the new year, and how this morning's strong GDP report will impact the Fed's next rate decision. Plus Shares of Novo Nordisk on the move as the pharma company's weight loss pill gets approved by the FDA. How the decision can tip the scales for Novo, and what one analyst sees in store for the weight loss drug space.Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Brain-computer interfaces are moving out of the lab and into real medical use. In this episode of The Michael Shermer Show, Michael Shermer talks with Dr. Matt Angle, founder and CEO of Paradromics, a neurotechnology company developing one of the most advanced high-data-rate brain implants in the world, similar to Neuralink. These devices record activity from individual neurons, making it possible to restore speech in people with paralysis, reconnect the brain to external devices, and potentially treat chronic pain and neurological disorders with far greater precision than existing approaches. Angle explains why progress in neuroscience has been limited not by biology, but by data—how much information we can actually read from the brain, and how fast. He describes how patients who can no longer speak may soon communicate fluently using only brain signals, why invasive implants can sometimes be safer than long-term drug treatments, and what it takes to bring a brain implant through FDA approval and into the clinic. The conversation also touches on the larger questions raised by this technology, including autonomy, consciousness, and what happens when the boundary between brain and machine begins to blur. Matt Angle is the Founder and CEO of Paradromics, a neurotechnology leader developing the world's most advanced and clinically viable brain-computer interface (BCI) platform—bridging human thought and digital capability. Paradromics' BCI platform records brain activity with unmatched precision, capturing data at the level of individual neurons. This advanced technology enables the decoding of vast amounts of brain data, opening the door to next-generation treatments for paralysis, chronic pain, addiction, mental health conditions, and more. With the power of AI, this platform has the potential to radically shift how healthcare providers approach some of the most challenging medical conditions. Angle earned his PhD in Neuroscience from the University of Heidelberg, followed by postdoctoral research at Stanford University. Paradromics engineered its first clinical product, the Connexus® BCI, received two FDA Breakthrough Device Designations, and performed the first-in-human neural recording in May 2025. The company is now preparing to launch a clinical trial in early 2026, pending regulatory approval.
What if healing didn't have to be solitary?What if family — messy, imperfect, deeply conditioned family — could actually be part of the medicine? In this episode of Why Isn't Everyone Doing This?, I sit down with Lauren Tauss, psychedelic facilitator, teacher, and one of the clearest communicators I know in this space. Lauren has a rare ability to bring humor, rigor, compassion, and responsibility into conversations that are often either sensationalized or sanitized. We talk about why “life itself is psychedelic,” how healing is inherently relational, and what becomes possible when we stop treating transformation as something that happens in isolation. Lauren shares her own deeply personal journey — from anorexia and control to surrender, embodiment, and trust — and how psychedelic-assisted therapy helped rewire her relationship with her body, her family, and life itself. This conversation isn't about glorifying substances or breaking taboos for shock value. It's about maturity. Integration. And learning how to say hello to yourself — instead of checking out. If you've ever been curious, cautious, skeptical, or quietly fascinated by psychedelic healing… this episode will meet you with intelligence and heart. In this episode, we explore: • Why Lauren says “life is the biggest psychedelic” • The difference between using medicine to say hello vs. goodbye • How relational healing changes family systems • Why shame, addiction, and “drug” culture need a language upgrade • The connection between meditation, surrender, and psychedelic work • Healing body image, control, and fear at the root• What integration actually means (and why it matters more than the experience) Key Moments: 00:00:00 — Why isn't everyone tripping with their family? 00:03:35 — “Life is the ceremony”: redefining what psychedelic really means 00:06:26 — Hello vs. goodbye: the two reasons people partner with substances 00:07:47 — Compassion over judgment in addiction and numbing 00:09:15 — Lauren's first ayahuasca experience and healing anorexia 00:12:27 — “It's time to retire your extra-small life” 00:14:41 — Body as gift: remembering the blessing of being alive 00:15:49 — Why meditation is surrender school (and prepares you for life) Where This Work Continues If this conversation stirred something in you, especially around integration, relationship, or embodiment, you may feel drawn to Level 3. Level 3 is where we focus on building the inner stability, nervous system resilience, and daily practices that allow deep experiences (psychedelic or otherwise) to actually change how you live. Learn more about Level 3 here:
A strike on another suspected drug trafficking boat in the Pacific is again escalating tensions between US and Venezuela. Five people are dead after a plane crash off the coast of Texas. The FDA has approved a pill version of Wegovy. President Donald Trump made his first public comments on the latest release of the Epstein files. Plus, the Kansas City Chiefs are leaving Kansas City, Missouri. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Carl Quintanilla and Jim Cramer led off show with the weight loss drug wars: Shares of Novo Nordisk shares surged after the FDA approved the company's Wegovy pill — making it the first oral GLP-1 cleared by regulators for treatment of obesity. ServiceNow CEO Bill McDermott joined the program to discuss his company's deal to acquire cybersecurity startup Armis for $7.75 billion in cash. Hear what McDermott had to say about this year's slump in shares of ServiceNow and other software stocks. Also in focus: Q3 GDP shows 4.3% growth, the AI trade, countdown to Christmas and new data on holiday spending, Tesla gets a big price target boost on Wall Street, the stock that's getting a lift from President Trump's battleship announcement. Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The FDA approving the first GLP-1 pill for obesity from Wegovy maker Novo Nordisk. CNBC speaking with the CEO about expanding access and how the pill will increase the company's competitive edge. Then, former U.K. Treasury Minister Jim O'Neill. His outlook for global markets. And President Trump saying “aggressive housing reform” is coming next year. UBS helps look at possible policy changes and the impact to stocks in the sector. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The Justice Department released its largest batch of Epstein files to date overnight. This collection includes tens of new documents, emails, photos and videos that are now publicly available. Plus, President Donald Trump is rolling out plans for the “Golden Fleet,” a new generation of massive American battleships he said will be the most powerful ever built. And a major shift in the weight-loss drug boom. The FDA has approved the first GLP-1 pill for obesity, with no injections required. These stories and more highlight your Unbiased Updates for Tuesday, December 23, 2025.
In this episode of Food Safety Matters, we discuss the top food safety stories of 2025 and their implications. We cover: The Trump Administration's impact on federal agencies overseeing food safety [7:52]: FDA, CDC Ordered to Temporarily Pause All External Communications, Obtain Trump Admin Approval RFK Jr. Confirmed as HHS Secretary; Widespread Firings Coming to FDA, CDC USDA Inspector General Phyllis Fong Dismissed by Trump Administration Brooke Rollins Confirmed as Secretary of Agriculture, Cites 'Aggressive Plan' to Eliminate USDA Jobs FDA Leader Jim Jones Resigns After 89 'Indiscriminate' Firings in Human Foods Program Attorney Kyle Diamantas Expected to Replace Jim Jones as FDA Deputy Commissioner of Human Foods FDA Spending Freeze Leaves Staffers Feeling 'Dangerously Unprepared' for Next Foodborne Illness Outbreak Federal Workforce Data Reveal Impact of Trump Admin RIFs on USDA Food Safety Expertise More Than 15,000 USDA Employees Take Trump Administration's Resignation Offer FDA Suspends Milk Quality Testing Amid Health and Human Services Cuts Entire Departments of CDC Outbreak Experts Fired, Rehired During Shutdown RIFs FDA Reportedly Reinstating Some Fired Food Safety Scientists, Inspection Support Staff Government Shutdown Affects Food Safety: HHS Furloughs Employees, FDA Pauses CORE Investigation Table Ep. 196. Dr. Lane Highbarger: How the FDA Workforce Cuts May Impact Food Safety Dozens of Prominent Food Safety Stakeholders Call for Reinstatement of NACMCF and NACMPI USDA Withdraws Proposed Regulatory Framework for Salmonella in Poultry After Years of Development USDA Indefinitely Delays Enforcement of Salmonella as Adulterant in Raw Breaded, Stuffed Chicken CDC Slashes FoodNet Surveillance From Eight Foodborne Pathogens to Two Public Health Professionals, Groups Demand Resignation of HHS Secretary RFK Jr. Trump-Appointed CDC Director Dr. Susan Monarez Fired After Clashes With Secretary Kennedy RFK Jr.'s Second in Command Named CDC Acting Director Following Sudden Firing Federal Layoffs to Hit HHS Amid Government Shutdown, May Affect Food Safety Staffers FDA Delays FSMA 204 Traceability Rule Compliance Date by 30 Months States and the "Make America Healthy Again" (MAHA) movement declare war on "toxic" food chemicals and ultra-processed foods (UPFs) [27:52]: FDA Announces Plan to Phase Out Synthetic, Petroleum-Based Food Dyes From U.S. Food Supply Bonus Episode: Diamantas and Choiniere: FDA Focuses on Produce Safety, MAHA, Culture, and More MAHA Report Sets Stage for Overhaul of Food Chemicals, Environmental Contaminants, and Childhood Nutrition What the Final MAHA Report Could Mean for Food Safety FDA Announces 'Proactive' Post-Market Chemical Review Program to Keep Food Supply Safe FDA Adds Six Artificial Food Dyes to List of Chemicals Under Post-Market Review FDA to Issue Proposed Rule Tightening GRAS Oversight FDA's Developing Rule to Tighten GRAS Oversight Moves to White House FDA, USDA Issue Joint RFI to Address the Risks of Ultra-Processed Foods California Enacts Law Defining Ultra-Processed Foods, Will Ban UPFs in Schools Food Industry Stakeholders Share Input on FDA, USDA's Intent to Define UPFs MAHA Pushback Kills 'Big Food'-Aligned Legislative Effort to Stop State Food Laws Industry Giants Support New Coalition Aimed at Stopping MAHA-Aligned State Food Additive Bans More Than 80 Groups Urge Congress Not to Block State Food Additives Bans Ep. 187. Rainer and Coneski: Evolving Legislation Around Food Packaging Chemicals and Additives—Implications for Industry Ep. 199. George Misko: The Future of Food Regulation Under MAHA Ep. 162. Brian Sylvester: How the California Food Safety Act is Shaping U.S. Food Additives Regulation Ep. 207. Brian Sylvester: Preparing for 'MAHA'-Driven Policy Changes on Food Dyes, UPFs, GRAS FDA's focus on infant formula safety and the infant botulism outbreak linked to ByHeart formula [57:44]: FDA Publishes Long-Term Strategy to Increase Resiliency of U.S. Infant Formula Market FDA Launches 'Operation Stork Speed' to Improve Infant Formula Safety, Including Contaminant Testing Infants Nationwide Hospitalized With Botulism After Consuming ByHeart Formula ByHeart Outbreak Grows: 31 Infants in 15 States Hospitalized for Botulism From Tainted Formula Infant Botulism Spike Exceeds 100 Cases, Extent of ByHeart's Involvement Unclear A History of Food Safety Failures at ByHeart, the Formula Company Behind Infant Botulism Outbreak ByHeart Finds Widespread Contamination in Infant Formula as Botulism Outbreak Grows; FDA Publishes Inspection Reports Coalition Urges RFK Jr. to Fix Infant Formula Oversight Problems that Allowed Infant Botulism Outbreak FDA Urges Industry to Improve Recall Efficiency After Delay in Removing ByHeart Formula from Stores Emerging science on Listeria monocytogenes and biofilms [1:08:26]: Study Shows Water Hoses as Reservoirs for Biofilms in Food Processing Facilities Study Demonstrates Listeria's Ability to Colonize, Survive in Preexisting Multispecies Biofilms First-of-its-Kind Study Shows How Listeria Strains Evolve Into Strong Biofilm Formers Study Explores Sanitizer Limitations Against Listeria Biofilms in Leafy Greens Production Listeria From Multispecies Biofilms More Prone to Growth in RTE Foods, Study Shows Study Shows Combining Antimicrobial Blue Light and Chemical Sanitizers Can Enhance Listeria Inactivation FAO/WHO Developing Risk Assessment Models for Listeria in Four Food Commodity Groups The ongoing Highly Pathogenic Avian Influenza H5N1 (HPAI H5N1) outbreak in U.S. dairy cattle and poultry flocks and continued monitoring to ensure food safety [1:14:09]: California Declares State of Emergency Over HPAI H5N1 Outbreak in Dairy Cows USDA Begins Five-Part National Milk Testing Strategy for HPAI H5N1 USDA Extends H5N1 Testing in Dairy Cattle; EU Releases Guidance on Avian Flu Prevention CDC: Avoid Consuming Raw Milk, as Risk of Bird Flu Infection is Low but Possible FDA-Backed Study Shows Aging Raw Milk Cheese Does Not Inactivate Avian Flu, but Low pH Helps Study Shows Avian Flu Does Not Pose Food Safety Risk in Various Pasteurized Dairy Products USDA to Invest in Farm Biosecurity, Chicken Vaccinations to Combat Avian Influenza Study Shows Acidification is Inexpensive, Easy Way to Inactivate Bird Flu in Raw Waste Milk FDA Now Requires Raw Pet Food Manufacturers to Consider HPAI in Food Safety Plans House Cat Dies After Eating Raw Pet Food Contaminated With HPAI H5N1 FDA-Backed Study Shows Aging Raw Milk Cheese Does Not Inactivate Avian Flu, but Low pH Helps H5N1 and the Growing Risk to Food Safety—Why Raw Milk Requires Special Attention FDA Begins Testing Assignment for HPAI H5N1 in Aged Raw Cow Milk Cheese FAO Encourages All Countries to Monitor for HPAI H5N1 Spread to Cattle Dutch Field Studies Show Promise for Two Experimental Avian Flu H5N1 Vaccines Federal Workforce Data Reveal Impact of Trump Admin RIFs on USDA Food Safety Expertise Growing artificial intelligence (AI) applications for food safety [1:17:57]: FAO Report Highlights Needs for Responsible AI Adoption in Food Safety Fields FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Agency-Wide AI Rollout Timeline Using AI, Researchers Offer Promising Real-Time Mycotoxin Detection Method for Foods Big Data, AI, and the Coming Philosophical Challenges with Food Safety Welcome to the Machine: AI and Potential Implications for the Food Industry Ep. 193. Christian Ararat: A Global Perspective on Auditing, Certifications, AI, and Beyond Ep. 205. Black and Gabor: Digital Transformation and Emerging International Standards for Food Safety We Want to Hear from You! Please send us your questions and suggestions to podcast@food-safety.com
The FDA has approved subcutaneous amivantamab. Join host Dr. Narjust Florez and guests, Dr. Natasha Leighl and Dr. Federico Cappuzzo, as they explore the science and convenience factor, as well as what this shift means for patients, clinicians, and oncology practice.
Angel Studios https://Angel.com/HermanJoin the Angel Guild today where you can stream Thank You, Dr. Fauci and be part of the conversation demanding truth and accountability. Renue Healthcare https://Renue.Healthcare/ToddYour journey to a better life starts at Renue Healthcare. Visit https://Renue.Healthcare/Todd Bulwark Capital https://KnowYourRiskPodcast.comBe confident in your portfolio with Bulwark! Schedule your free Know Your Risk Portfolio review. Go to KnowYourRiskPodcast.com today. Alan's Soaps https://www.AlansArtisanSoaps.comUse coupon code TODD to save an additional 10% off the bundle price.Bonefrog https://BonefrogCoffee.com/ToddThe new GOLDEN AGE is here! Use code TODD at checkout to receive 10% off your first purchase and 15% on subscriptions.LISTEN and SUBSCRIBE at:The Todd Herman Show - Podcast - Apple PodcastsThe Todd Herman Show | Podcast on SpotifyWATCH and SUBSCRIBE at: Todd Herman - The Todd Herman Show - YouTubeJenner Furst, director of the latest Angel Studios documentary "Thank You Dr. Fauci" joins the show.Episode Links:Thank You Dr. Fauci | Now Streaming | AngelBREAKING/URGENT: mRNA COVID VACCINES KILLED AT LEAST 10 KIDS, THE FDA REPORTS; An FDA review found the shots to blame for the deaths, FDA's new vaccine chief - Dr. Vinay Prasad - told staffers in an email. The agency will tighten standards on new vaccine approval, Prasad wrote.Fauci's Ebola stuntURGENT: mRNA Covid jabs should NEVER have been approved for children or young adults Pfizer, Moderna, the Biden Administration, and everyone in public health who pushed these for kids and teens have blood on their handsUnmask The Truth | Official Clip | Thank You, Dr. Fauci
In this live episode, Tricia Eastman joins to discuss Seeding Consciousness: Plant Medicine, Ancestral Wisdom, Psychedelic Initiation. She explains why many Indigenous initiatory systems begin with consultation and careful assessment of the person, often using divination and lineage-based diagnostic methods before anyone enters ceremony. Eastman contrasts that with modern frameworks that can move fast, rely on short trainings, or treat the medicine as a stand-alone intervention. Early Themes: Ritual, Preparation, and the Loss of Container Eastman describes her background, including ancestral roots in Mexico and her later work at Crossroads Ibogaine in Mexico, where she supported early ibogaine work with veterans. She frames her broader work as cultural bridging that seeks respect rather than fetishization, and assimilation into modern context rather than appropriation. Early discussion focuses on: Why initiatory traditions emphasize purification, preparation, and long timelines Why consultation matters before any high-intensity medicine work How decades of training shaped traditional initiation roles Why people can get harmed when they treat medicine as plug and play Core Insights: Alchemy, Shadow, and Doing the Work A major throughline is Eastman's critique of the belief that a psychedelic alone will erase trauma. She argues that shadow work remains part of the human condition, and that healing is less about a one-time fix and more about building capacity for relationship with the unconscious. Using alchemical language, she describes "nigredo" as fuel for the creative process, not as something to eliminate forever. Key insights include: Psychedelics are tools, not saviors You cannot outsource responsibility to a pill, a modality, or a facilitator Progress requires practice, discipline, and honest engagement with what arises "Healing" often shows up as obstacles encountered while trying to live and create Later Discussion and Takeaways: Iboga, Ethics, and Biocultural Stewardship Joe and Tricia move into a practical and ethically complex discussion about iboga supply chains, demand pressure, and the risks of amplifying interest without matching it with harm reduction and reciprocity. Eastman emphasizes medical screening, responsible messaging, and supporting Indigenous-led stewardship efforts. She also warns that harm can come from both under-trained modern facilitators and irresponsible people claiming traditional legitimacy. Concrete takeaways include: Treat iboga and ibogaine as high-responsibility work that demands safety protocols Avoid casual marketing that encourages risky self-administration Support Indigenous-led biocultural stewardship and reciprocity efforts Give lineage carriers a meaningful seat at the table in modern policy and clinical conversations Frequently Asked Questions Who is Tricia Eastman? Tricia Eastman is an author, facilitator, and founder of Ancestral Heart. Her work focuses on cultural bridging, initiation frameworks, and Indigenous-led stewardship. What is Seeding Consciousness about? The book examines plant medicine through initiatory traditions, emphasizing consultation, ritual, preparation, and integration rather than reductionistic models. Why does Tricia Eastman critique modern psychedelic models? She argues that many models remove the ritual container and long-form preparation that reduce risk and support deeper integration. Is iboga or ibogaine safe? With the right oversite, yes. Eastman stresses that safety depends on cardiac screening, careful protocols, and experienced oversight. She warns against informal or self-guided use. How can people support reciprocity and stewardship? She encourages donating or supporting Indigenous-led biocultural stewardship initiatives like Ancestral Heart and aligning public messaging with harm reduction. Closing Thoughts This episode makes a clear case that Tricia Eastman Seeding Consciousness is not only a book about psychedelics, but a critique of how the field is developing. Eastman argues that a successful future depends on mature containers, serious safety culture, and respectful partnership with lineage carriers, especially as interest in iboga and ibogaine accelerates. Links https://www.ancestralheart.com https://www.innertraditions.com/author/tricia-eastman Transcript Joe Moore Hello, everybody. Welcome back. Joe Moore with you again from Psychedelics Today, joined today by Tricia Eastman. Tricia, you just wrote a book called Seeding Consciousness. We're going to get into that a bunch today, but how are you today? [00:00:16.07] - Tricia Eastman I'm so good. It's exciting to be live. A lot of the podcasts I do are offline, and so it's like we're being witnessed and feels like just can feel the energy behind It's great. [00:00:31.11] - Joe Moore It's fun. It's a totally different energy than maybe this will come out in four months. This is real, and there's people all over the world watching in real-time. And we'll get some comments. So folks, if you're listening, please leave us some comments. And we'd love to chat a little bit later about those. [00:00:49.23] - Tricia Eastman I'm going to join the chat so that I can see... Wait, I just want to make sure I'm able to see the comments, too. Do I hit join the chat? [00:01:01.17] - Joe Moore Sometimes you can, sometimes you can't. I can throw comments on the screen so we can see them together. [00:01:07.02] - Tricia Eastman Cool. [00:01:08.03] - Joe Moore Yeah. So it'll be fun. Give us comments, people. Please, please, please, please. Yeah, you're all good. So Tricia, I want to chat about your book. Tell us high level about your book, and then we're going to start digging into you. [00:01:22.10] - Tricia Eastman So Seeding Consciousness is the title, and I know it's a long subtitled Plant Medicine, Ancestral Wisdom, Psychedelic Initiation. And I felt like it was absolutely necessary for the times that we are in right now. When I was in Gabon in 2018, in one of my many initiations, as as an initiative, the Fung lineage of Buiti, which I've been practicing in for 11 years now, I was given the instructions. I was given the integration homework to write this book. And I would say I don't see that as this divine thing, like you were given the assignment. I think I was given the assignment because it's hard as F to write a book. I mean, it really tests you on so many levels. I mean, even just thinking about putting yourself out there from a legal perspective, and then also, does it make any sense? Will anyone buy it? And on Honestly, it's not me. It's really what I was given to write, but it's based on my experience working with several thousand people over the years. And really, the essence of it is that in our society, we've taken this reductionistic approach in psychedelics, where we've really taken out the ritual. [00:02:54.05] - Tricia Eastman Even now with the FDA trial for MDMA for PTSD. There's even conversations with a lot of companies that are moving forward, psychedelics, through the FDA process, through that pathway, that are talking about taking the therapy out. And the reality is that in these ancient initiatic traditions, they were very long, drawn out experiences with massive purification rituals, massive amounts of different types of practice in order to prepare oneself to meet the medicine. Different plants were taken, like vomatifs and different types of purification rituals were performed. And then you would go into this profound initiatic experience because the people that were working with you that were in, we call it the Nema, who gives initiations, had decades of training and experience doing these types of initiatic experiences. So if you compare that to the modern day framework, we have people that go online and get a certificate and start serving people medicine or do it in a context where maybe there isn't even an established container or facilitator whatsoever. And so really, the idea is, how can we take the essence of this ancient wisdom wisdom, like when you look at initiation, the first step is consultation, which is really going deep into the history of the individual using different types of techniques that are Indigenous technologies, such as different forms of divination, such as cowrie shell readings. [00:04:52.18] - Tricia Eastman And there's different types of specific divinations that are done in different branches of And before one individual would even go into any initiation, you need to understand the person and where they're coming from. So it's really about that breakdown of all of that, and how can we integrate elements of that into a more modern framework. [00:05:24.23] - Joe Moore Brilliant. All right. Well, thank you for that. And let's chat about you. You've got a really interesting past, very dynamic, could even call it multicultural. And you've got a lot of experience that informed this book. So how did this stuff come forward for you? [00:05:50.02] - Tricia Eastman I mean, I've never been the person to seek anything. My family on my mother's side is from Mexico, from Oaxaca, Trique, Mixtec, and Michica. And we had a long lineage of practice going back to my, at least I know from my great, great grandmother, practicing a blend of mestiza, shamanism, combining centerea and Catholicism together. So it's more of like a syncratic mestiza, mestiza being mixed tradition. And so I found it really interesting because later on, when my grandfather came to the United States, he ended up joining the military. And in being in the US, he didn't really have a place. He's very devout spiritual man, but he didn't have a place to practice this blended spiritual tradition. So the mystical aspect of it went behind. And as I started reconnecting to my ancestral lineage, this came forth that I was really starting to understand the mystical aspect of my ancestry. And interestingly, at the same time, was asked to work at Crossroads Abigain in Mexico. And it's so interesting to see that Mexico has been this melting pot and has been the place where Abigain has chosen to plant its roots, so to say, and has treated thousands of veterans. [00:07:36.28] - Tricia Eastman I got to be part of the group of facilitators back over 10 years ago. We treated the first Navy Seals with Abogaine, and that's really spurred a major interest in Abogaine. Now it's in every headline. I also got 10 I got initiated into the Fung lineage of Buiti and have really studied the traditional knowledge. I created a nonprofit back in 2019 called Ancestral Heart, which is really focused on Indigenous-led stewardship. Really, the book helps as a culmination of the decade of real-world experience of combining My husband, Dr. Joseph Barzulia. He's a psychologist. He's also a pretty well-known published researcher in Abigain and 5MEO-DMT, but also deeply spiritual and deeply in respect for the Indigenous traditions that have carried these medicines before us. So we've really been walking this complex path of world bridging between how we establish these relationships and how we bring some of these ancient knowledge systems back into the forefront, but not in a way of fetishizing them, but in a way of deeply respecting them and what we can learn, but from our own assimilation and context versus appropriation. So really, I think the body of my work is around that cultural bridging. [00:09:31.07] - Joe Moore That's brilliant. And yeah, there's some really fun stuff I learned in the book so far that I want to get into later. But next question is, who is your intended audience here? Because this is an interesting book that could hit a few categories, but I'm curious to hear from you. [00:09:49.02] - Tricia Eastman It's so funny because when I wrote the book, I wasn't thinking, oh, what's my marketing plan? What's my pitch? Who's my intended audience? Because it was my homework, and I knew I needed to write the book, and maybe that was problematic in the sense that I had to go to publishers and have a proposal. And then I had to create a formula in hindsight. And I would say the demographic of the book mirrors the demographic of where people are in the psychedelic space, which It's skewed slightly more male, although very female. I think sex isn't necessarily important when we're thinking about the level of trauma and the level of spiritual healing and this huge deficit that we have in mental health, which is really around our disconnection from our true selves, from our heart, from our souls, from this idea of of what Indigenous knowledge systems call us the sacred. It's really more of an attitude of care and presence. I'm sure we could give it a different name so that individuals don't necessarily have any guard up because we have so much negative conditioning related to the American history of religion, which a lot of people have rejected, and some have gone back to. [00:11:37.06] - Tricia Eastman But I think we need to separate it outside of that. I would say the demographic is really this group of I would say anywhere from 30 to 55 male females that are really in this space where maybe they're doing some of the wellness stuff. They're starting to figure some things out, but it's just not getting them there. And when something happens in life, for example, COVID-19 would be a really great example. It knocks them off course, and they just don't have the tools to find that connection. And I would say it even spans across people that do a lot of spiritual practice and maybe are interested in what psychedelics can do in addition to those practices. Because when we look at my view on psychedelics, is they fit within a whole spectrum of wellness and self-care and any lineage of spiritual practice, whether it's yoga or Sufism or Daoist tradition. But they aren't necessarily the thing that... I think there's an over focus on the actual substance itself and putting it on a pedestal that I think is problematic in our society because it goes back to our religious context in the West is primarily exoteric, meaning that we're seeking something outside of ourselves to fulfill ourselves. [00:13:30.29] - Tricia Eastman And so I think that when we look at psychedelic medicines as this exoteric thing versus when we look at initiatory traditions are about inward and direct experience. And all of these spiritual practices and all of these modalities are really designed to pull you back into yourself, into having a direct relationship with yourself and direct experience. And I feel like the minute that you are able to forge that connection, which takes practice and takes discipline, then you don't need to necessarily look at all these other tools outside of yourself. It's like one of my favorite analogies is the staff on the Titanic were moving the furniture around as it was sinking, thinking that they might save the boat from sinking by moving the furniture around. I think that's how we've been with a lot of ego-driven modalities that aren't actually going into the full unconscious, which is where we need to go to have these direct experiences. Sorry for the long answer, but it is for everybody, and it's not just about psychedelics. Anyone can take something from this doing any spiritual work. But we talk a lot about the Indigenous philosophy and how that ties in alongside with spiritual practice and more of this inner way of connecting with oneself and doing the work. [00:15:21.22] - Tricia Eastman And I think also really not sugar coating it in the sense that the psychedelics aren't going to save us. They're not going to cure PTSD. Nothing you take will. It's you that does the work. And if you don't do the work, you're not going to have an 87 % success rate with opioid use disorder or whatever it is, 60 something % for treatment-resistant depression or whatever. It's like you have to do the work. And so we can't keep putting the power in the modality reality or the pill. [00:16:03.18] - Joe Moore Yeah, that makes sense. So you did an interesting thing here with this book, and it was really highlighting aspects of the alchemical process. And people don't necessarily have exposure. They hear the words alchemy. I get my shoulders go up when I hear alchemizing, like transmutation. But it's a thing. And how do we then start communicating this from Jung? I found out an interesting thing recently as an ongoing student. Carl Jung didn't necessarily have access to all that many manuscripts. There's so many alchemical manuscripts available now compared to what he had. And as a result, our understanding of alchemy has really evolved. Western alchemy, European alchemy, everybody. Perhaps Kmetic, too. I don't know. You could speak to that more. I don't keep track of what's revealed in Egypt. So it's really interesting to present that in a forward way? How has it been received so far? Or were you nervous to present this in this way? [00:17:25.10] - Tricia Eastman I mean, honestly, I think the most important The important thing is that in working with several thousand people over the years, people think that taking the psychedelic and the trauma is going to go away. It's always there. I mean, we We archetypically will have the shadow as long as we need the shadow to learn. And so even if we go into a journey and we transcend it, it's still there. So I would say that the The feedback has been really incredible. I mean, the people that are reading... I mean, I think because I'm weaving so many different, complex and deep concepts into one book, it might be a little harder to market. And I think the biggest bummer was that I was really trying to be respectful to my elders and not say anything in the title about Iboga and Abigain, even though I talk a lot about it in the book, and it's such a hot topic, it's really starting to take off. But the people that have read it really consider it. They really do the work. They do the practices in the book, and I'm just getting really profound feedback. So that's exciting to me because really, ultimately, alchemy... [00:18:55.22] - Tricia Eastman Yeah, you're right. It gets used Used a lot in marketing lingo and sitting in the depth of the tar pit. For me, when I was in Gabon, I remember times where I really had to look at things that were so dark in my family history that I didn't even realize were mine until later connected to my lineage. And the dark darkness connected to that and just feeling that and then knowing really the truth of our being is that we aren't those things. We're in this process of changing and being, and so nothing is is fixed, but there is a alchemical essence in just learning to be with it. And so not always can we just be with something. And and have it change, but there are many times that we can actually just be with those parts of ourselves and be accepting, where it's not like you have to have this intellectualized process It's just like, first you have the negrado, then you tune into the albeda, and you receive the insights, and you journal about it, and da, da, da, da, da Action, Mars aspect of it, the rubeda of the process. It's not like that at all. [00:20:44.15] - Tricia Eastman It's really that the wisdom that comes from it because you're essentially digesting black goo, which is metaphoric to the oil that we use to power all of society that's pulled deep out of the Earth, and it becomes gold. It becomes... And really, the way I like to think of it is like, in life, we are here to create, and we are not here to heal ourselves. So if you go to psychedelic medicine and you want to heal yourself, you're going to be in for... You're just going to be stuck and burnt out because that's not what we're here to do as human beings, and you'll never run out of things to heal. But if you You think of the negrado in alchemy as gasoline in your car. Every time you go back in, it's like refilling your gas tank. And whatever you go back in for as you're moving in the journey, it's almost like that bit of negrado is like a lump of coal that's burning in the gas tank. And that gets you to the next point to which there's another thing related to the creative process. So it's like As you're going in that process, you're going to hit these speed bumps and these obstacles in the way. [00:22:07.29] - Tricia Eastman And those obstacles in the way, that's the healing. So if you just get in the car in the human vehicle and you drive and you continue to pull out the shadow material and face it, you're going to keep having the steam, but not just focus on it, having that intention, having that connection to moving forward in life. And I hate to use those words because they sound so growth and expansion oriented, which life isn't always. It's evolutionary and deevolutionary. It's always in spirals. But ultimately, you're in a creative process would be the best way to orient it. So I think when we look at alchemy from that standpoint, then it's productive. Effective. Otherwise, it sounds like some brand of truffle salt or something. [00:23:09.12] - Joe Moore Yeah, I think it's a... If people want to dig in, amazing. It's just a way to describe processes, and it's super informative if you want to go there, but it's not necessary for folks to do the work. And I like how you framed it quite a bit. So let's see. There is one bit, Tricia, that my ears really went up on this one point about a story about Actually, let me do a tangent for you real quick, and then we're going to come back to this story. So are you familiar with the tribe, the Dogon, in Africa? Of course. Yeah. So they're a group that looks as though they were involved in Jewish and/or Egyptian traditions, and then ended up on the far side of like, what, Western Africa, far away, and had their own evolution away from Egypt and the Middle East. Fascinating. Fascinating stories, fascinating astronomy, and much more. I don't know too much about the religion. I love their masks. But this drew an analogy for me, as you were describing that the Buiti often have stories about having lineage to pre-dynastic Egyptian culture. I guess we'll call it that for now, the Kometic culture. [00:24:44.23] - Joe Moore I had not heard that before. Shame on me because I haven't really read any books about Buiti as a religion or organization, or anything to this point. But I found that really interesting to know that now, at least I'm aware of two groups claiming lineage to that ancient world of magic. Can you speak about that at all for us? Yeah. [00:25:09.24] - Tricia Eastman So first off, there really aren't any books talking about that. Some of the things I've learned from elders that I've spoke with and asked in different lineages in Masoco and in Fong Buiti, there's a few things. One, We lived in many different eras. Even if you go into ancient texts of different religions, creation stories, and biblical stories, they talk about these great floods that wiped out the planet. One of the things that Atum talks about, who is one of my Buiti fathers who passed a couple years ago, is Is the understanding that before we were in these different areas, you had Mu or Lumaria, you had Atlantis, and then you had our current timeline. And the way that consciousness was within those timelines was very different and the way the Earth was. You had a whole another continent called Atlantis that many people, even Plato, talks about a very specific location of. And what happened, I believe during that time period, Africa, at least the Saharan band of the desert was much more lush, and it was a cultural melting pot. So if you think about, for example, the Pygmy tribes, which are in Equatorial Africa, they are the ones that introduced Iboga to the Buiti. [00:27:08.08] - Tricia Eastman If you look at the history of ancient Egypt, what I'm told is that the Pygmies lived in Pharaonic Egypt, all the way up until Pharaonic Egypt. And there was a village. And if you look on the map in Egypt, you see a town called Bawiti, B-A-W-I-T-I. And that is the village where they lived. And I have an interesting hypothesis that the God Bess, if you look at what he's wearing, it's the exact same to a T as what the Pygmies wear. And the inspiration for which a lot of the Buiti, because they use the same symbology, because each part of the outfit, whether it's the Mocingi, which is like this animal skin, or the different feathers, they use the parrot feather as a symbology of speech and communication, all of these things are codes within the ceremony that were passed along. And so when you look at Bess, he's wearing almost the exact same outfit that the Pygmies are wearing and very similar to if you see pictures of the ceremonies of Misoko or Gonde Misoko, which I would say is one of the branches of several branches, but that are closer to the original way of Buiti of the jungle, so closer to the way the Pygmies practice. [00:28:59.16] - Tricia Eastman So If you look at Bess, just to back my hypothesis. So you look at Neteru. Neteru were the... They called them the gods of Egypt, and they were all giant. And many say the word nature actually means nature, but they really represented the divine qualities of nature. There's best. Look at him. And a lot of the historians said he's the God of Harmeline and children and happiness. I think he's more than the God of Harmeline, and I think that the Pygmies worked with many different plants and medicines, and really the ultimate aspect of it was freedom. If you think about liberation, like the libation, number one, that's drunkiness. Number two, liberation, you of freeing the joyous child from within, our true nature of who we are. You look at every temple in Egypt, and you look at these giant statues, and then you have this tiny little pygmy God, and there's no other gods that are like Bess. He's one of a kind. He's in his own category. You've You've got giant Hathor, you've got giant Thoth, you've got giant Osiris, Isis, and then you've got little tiny Bess. And so I think it backs this hypothesis. [00:30:48.27] - Tricia Eastman And my understanding from practitioners of Dogon tradition is that they also believe that their ancestors came from Egypt, and they definitely have a lot of similarity in the teachings that I've seen and been exposed to just from here. I mean, you can... There's some more modern groups, and who's to know, really, the validity of all of it. But there are some, even on YouTube, where you can see there's some more modern Dogon temples that are talking in English or English translation about the teachings, and they definitely line up with Kamehdi teachings. And so my hypothesis around that is that the Dogon are probably most likely pygmy descendants as, And the pygmy were basically run out of Bawiti because there was jealousy with the priest, because there was competition, because all of the offerings that were being made in the temple, there was a lot of power, connected to each of the temples. And there was competitiveness even amongst the different temples, lining the Nile and all of that, of who was getting the most offerings and who was getting the most visits. And so the Pygmies essentially were run out, and they migrated, some of them migrated south to Gabon and Equatorial Africa. [00:32:43.07] - Tricia Eastman And then If you think about the physical changes that happened during these planetary catastrophes, which we know that there had been more than one based on many historical books. So that whole area went through a desertification process, and the Equatorial rainforest remained. So it's highly likely even that Iboga, at one point, grew in that region as well. [00:33:18.00] - Joe Moore Have you ever seen evidence of artwork depicting Iboga there in Egypt? [00:33:24.17] - Tricia Eastman There are several different death temples. I'm trying to remember the name of the exact one that I went to, but on the columns, it looked like Iboga trees that were carved into the columns. And I think what's interesting about this... So Seychet is the divine scribe, the scribe of Egyptian wisdom. And she was basically, essentially the sidekick of Thoth. Thoth was who brought a lot of the ancient wisdom and people like Pythagoras and many of the ancient philosophers in Roman times went and studied in a lot of these Thoth lineage mystery schools. When you look at the the river of the Nile on the east side, east is the energy liturgy of initiation. It's always like if you go into a sweat lodge or if you see an ancient temple, usually the doorway is facing the east. West is where the sun sets, and so that's the death. And what's interesting about that is that it was on the west side in the death temple that you would see these aboga plants. But also Seixat was the one who was the main goddess depicted in the hieroglyphs, and there was other hieroglyphs. I mean, if you look at the hieroglyphs of Seixat, it looks like she has a cannabis leaf above her head, and a lot of people have hypothesized that, that it's cannabis. [00:35:16.03] - Tricia Eastman Of course, historians argue about that. And then she's also carrying a little vessel that looks like it has some mushrooms in it. And obviously, she has blue Lotus. Why would she be carrying around blue Lotus and mushrooms? I don't know. It sounds like some initiation. [00:35:36.19] - Joe Moore Yeah, I love that. Well, thanks so much for going there with me. This photo of Seixet. There's some good animations, but everybody just go look at the temple carvings picturing this goddess. It's stunning. And obviously, cannabis. I think it's hard to argue not. I've seen all these like, mushroom, quote, unquote, mushroom things everywhere. I'm like, Yeah, maybe. But this is like, Yes, that's clear. [00:36:06.27] - Tricia Eastman And if you look at what she's wearing, it's the exact same outfit as Bess, which is classic Basically, how the medicine woman or medicine man or what you would call shaman, the outfit that the healers would wear, the shamans or the oracles, those of the auracular arts, different forms of divination would wear. So if you really follow that and you see, Oh, what's Isis wearing? What's Hathor wearing? What's Thoth wearing? You can tell she's very specifically the healer. And it's interesting because they call her the divine scribe. So she's actually downloading, my guess is she's taking plants and downloading from the primordial. [00:37:02.00] - Joe Moore Well, okay. Thanks for bringing that up. That was a lovely part of your book, was your... There's a big initiation sequence, and then you got to go to this place where you could learn many things. Could you speak to that a little bit? And I hope that's an okay one to bring up. [00:37:22.22] - Tricia Eastman Are you talking about the time that I was in initiation and I went to the different ashrams, the different realms in, like Yogananda calls them astral schools that you go and you just download? It seemed like astral schools, but it seemed like it was a Bwiti initiation, where you were in silence for three days, and then Yeah, that one. So there were several different... I mean, I've done seven official initiations, and then I've had many other initiatic experiences. And I would say this one was incredible. Incredibly profound because what it showed me first was that all of the masters of the planet, it was showing me everyone from Kurt Cobain to Bob Marley to Einstein, all the people that had some special connection to an intelligence that was otherworldly, that they were essentially going to the same place, like they were visiting the same place, and they would go. And so the first thing I noticed was that I recognized a lot of people, and current, I'm not going I don't want to say names of people, but I recognize people that are alive today that I would say are profound thinkers that were going to these places as well. [00:38:57.05] - Tricia Eastman And interestingly, then I was taken into one of the classrooms, and in the classroom, this one, specifically, it showed me that you could download any knowledge instantaneously That essentially, having a connection to that school allowed you to download music or understand very complex ideas ideas of mathematics or physics or science that would take people like lifetimes to understand. So it was essentially showing this. And a lot of people might discredit that, that that might be a specific... That we as humans can do that. Well, I'm not saying that it's not that. I don't I don't want to say that it's anything. But what I can say is that I have definitely noticed the level of access that I have within my consciousness. And also what I notice with the masters of Bwiti, specifically in terms of the level of intelligence that they're accessing and that it's different. It's got a different quality to it. And so it was a really profound teaching. And one of the things, too, that I've learned is I use it to help me learn specific things. I don't know if I can give a positive testimonial, but I am learning French. [00:40:55.00] - Tricia Eastman And I noticed when I was in Aspen at the Abigain meeting, and I was with Mubeiboual, who speaks French, I started saying things French that I didn't even realize that I knew to say. I've had these weird moments where I'm actually using this tool And I'm also using it. I have a Gabonese harp. I don't know if you can see it up on the shelf over there. But I also went and asked for some help with downloading some assistance in the harp, then we'll see how that goes. [00:41:38.17] - Joe Moore Yeah. So that's brilliant. I'm thinking of other precedent for that outside of this context, and I can think of a handful. So I love that, like savant syndrome. And then there's a classic text called Ars Notoria that helps accelerate learning, allegedly. And then there's a number of other really interesting things that can help us gain these bits of wisdom and knowledge. And it does feel a little bit like the Dogon. The story I get is the receiving messages from the dog star, and therefore have all sorts of advanced information that they shouldn't we call it. Yeah. Yeah, which is fascinating. We have that worldwide. I think there's plenty of really interesting stuff here. So what I appreciated, Tricia, about how you're structuring your book, or you did structure your book, is that it it seems at the same time, a memoir, on another hand, workbook, like here are some exercises. On the other hand, like here's some things you might try in session. I really appreciated that. It was like people try to get really complicated when we talk about things like IFS. I'm like, well, you don't necessarily have to. You could. Or is this just a human thing, a human way to look at working with our parts? [00:43:20.15] - Joe Moore I don't know. Do you have any thoughts about the way you were approaching this parts work in your book versus how complicated some people make it feel? [00:43:30.00] - Tricia Eastman Yeah. I find that this is just my personal opinion, and no way to discredit Richard Schwartz's work. But parts work has existed in shamanism since forever. When we really look at even in ancient Egypt, Issus, she put Osiris act together. That was the metaphorical story of soul retrieval, which is really the spiritual journey of us reclaiming these pieces of ourselves that we've been disconnected from a society level or individually. And within the context of parts work, it's very organic and it feels other worldly. It's not like there's ever a force where I'm in the process with someone. And a lot of times I would even go into the process with people because they weren't accustomed to how to work with Iboga or game, and so they would be stuck. And then the minute I was like, you know, Iboga, in the tradition, it's really about... It's like the game Marco Polo. It's call and response. And so you're really an active participant, and you're supposed to engage with the spirits. And so the minute that things would show up, it'd be more about like, oh, what do you see? What's coming up here? Asking questions about it, being curious. [00:45:17.07] - Tricia Eastman If you could engage with it, sometimes there's processes where you can't really engage with things at all. So everything that I'm talking about is It was organically shown up as an active engagement process that it wasn't like we were going in. There have been some where you can guide a little bit, but you never push. It might be something like, go to your house, and it being completely unattached. And if they can't go there, then obviously the psyche doesn't want to go there, but it's really an exercise to help them to connect to their soul. And then in contrast, IFS is like, let's work on these different parts and identify these different parts of ourselves. But then let's give them fixed titles, and let's continually in a non-altered state of consciousness, not when we're meditating, not when we're actively in a state where we have the plasticity to change the pathway in the unconscious mind, but we're working in the egoic mind, and we're talking to these parts of ourselves. That could be helpful in the day-to-day struggles. Let's say you have someone who has a lot of rumination or a very active mind to have something to do with that. [00:46:57.01] - Tricia Eastman But that's not going to be the end-all, be-all solution to their problem. It's only moving the deck chairs around on the Titanic because you're still working in the framework where, I'm sorry, the Titanic is still sinking, and it may or may not be enough. It may or may not produce a reliable outcome that could be connected with some level of true relief and true connection within oneself. And so I think that people just... I feel like they almost get a little too... And maybe it's because we're so isolated and lonely, it's like, Oh, now I've got parts. I'm not by myself. I've got my fire I've got my firefighter, and I've got my guardian, and all these things. And I definitely think that IFS is a really great initiator into the idea of engaging with parts of ourselves and how to talk to them. But I don't think it's... And I think doing a session here and there, for some people, can be incredibly helpful, but to all of a sudden incorporate it in like a dogma is toxic. It's dangerous. And that's what we have to be really careful of. [00:48:23.25] - Joe Moore So thank you for that. There's a complicated discussion happening at the Aspen meeting. I think I was only sitting maybe 30 feet away from you. Sorry, I didn't say hi. But the folks from Blessings of the Forest were there, and I got a chance to chat with a number of them and learn more about nuclear protocols, biopiracy, literal piracy, and smuggling, and the works. I'm curious. This is a really complicated question, and I'm sorry for a complicated question this far in. But it's like, as we talk about this stuff publicly and give it increased profile, we are de facto giving more juice and energy to black markets to pirate. We're adding fuel to this engine that we don't necessarily want to see. Cameroon has nothing left, pretty much. From what I'm told, people from Cameroon are coming in, stealing it from Cabona, bringing it back, and then shipping it out. And there's It's like a whole worldwide market for this stuff. I witnessed it. This stuff. Yeah, right? This is real. So the people, the Buiti, and certain Gabanese farmers, are now being pirated. And international demand does not care necessarily about Nagoya compliance. United States didn't sign Nagoya protocol for this biopiracy protection, but we're not the only violator of these ethics, right? [00:50:00.22] - Joe Moore It's everywhere. So how do we balance thinking about talking about IBOCA publicly, given that there's no clean way to get this stuff in the United States that is probably not pirated materials? And as far as I know, there's only one, quote unquote, Nagoya compliant place. I've heard stories that I haven't shared publicly yet, that there's other groups that are compliant, too. But it's a really interesting conversation, and I'm curious of your perspectives there. [00:50:34.04] - Tricia Eastman I mean, this is a very long, drawn-out question, so forgive me if I give you a long, drawn-out answer. [00:50:41.01] - Joe Moore Go for it. [00:50:41.26] - Tricia Eastman It's all good. So in reality, I do believe... You know the first Ebo, Abogaine, that was done in the country was experiments on eight Black prisoners at a hospital under the MK program. [00:51:01.16] - Joe Moore Pre-lutz off, we were doing Abogaine tests on people. [00:51:06.00] - Tricia Eastman Yeah, so pre-Lutz off. I have a hypothesis, although a lot of people would already know me. [00:51:12.07] - Joe Moore No, I didn't know that. Thank you for sharing that with me. [00:51:14.13] - Tricia Eastman That's great. I'll send you some stuff on that. But the Aboga wanted to be here. The Abogaine wanted to be here. I think it's a complex question because on one side of the coin, you have the spirit of plants, which are wild and crazy sometimes. And then you have the initiatory traditions, which create a scaffolding to essentially put the lightning in a bottle, so to say, so that it's less damaging. [00:51:51.13] - Joe Moore It's almost like a temple structure around it. [00:51:53.16] - Tricia Eastman I like that. Yeah. Put a temple structure around it because it's like, yeah, you can work with new nuclear energy, but you have to wear gloves, you have to do all these different safety precautions. I would say that that's why these traditions go hand in hand with the medicine. So some people might say that the agenda of Iboga and even Abogaine might be a different agenda than the Buiti. And ultimately, whether we are Indigenous or not, the Earth belongs to everyone. It's capitalism and the patriarchy that created all these borders and all these separations between people. And in reality, we still have to acknowledge what the essence of Buiti is, which is really the cause and effect relationship that we have with everything that we do. And so some people might use the term karma. And that is if you're in Abogaine clinic and you're putting a bunch of videos out online, and that's spurring a trend on TikTok, which we already know is a big thing where people are selling illegal market, iBoga, is Is any of that your responsibility? Yes. And if I was to sit down with a kogi kagaba, which are the mamus from Colombia, or if I were to sit down with a who said, Hey, let's do a divination, and let's ask some deep questions about this. [00:53:54.01] - Tricia Eastman It would look at things on a bigger perspective than just like, Oh, this person is completely responsible for this. But when we're talking about a medicine that is so intense, and when I was younger, when I first met the medicine, I first was introduced in 2013 was when I first found out about Abigain and Iboga. And in 2014, I lived with someone who lived with a 14th generation Misoko, maybe it was 10th generation Misoco in Costa Rica. And then he decided to just start serving people medicine. And he left this person paralyzed, one person that he treated for the rest of his life. And Aubrey Marcus, it was his business partner for On It, and he's publicly talked about this, about the story behind this. If you go into his older podcasts and blog posts and stuff, he talks about the situation. And the reality is that this medicine requires a massive amount of responsibility. It has crazy interactions, such as grapefruit juice, for example, and all kinds of other things. And so it's not just the responsibility towards the buiti, it's also the responsibility of, does me talking about this without really talking about the safety and the risks, encourage other people. [00:55:49.10] - Tricia Eastman One of the big problems, back in the day, I went to my first guita conference, Global Abogaine Therapy Alliance in 2016. And And then, ISEARs was debating because there was all these people buying Abogaine online and self-detoxing and literally either dying or ending up in the hospital. And they're like, should we release protocols and just give people instructions on how to do this themselves? And I was like, no, absolutely not. We need to really look at the fact that this is an initiatory tradition, that it's been practiced for thousands of that the minimum level at which a person is administering in Gabon is 10 years of training. The way that we've made up for those mistakes, or sorry, not mistakes, lack of training is that we've used medical oversight. Most of the medical oversight that we've received has been a result of mistakes that were made in the space. The first patient that MAPS treated, they killed them because they gave them way over the amount of what milligrams per kilogram of Abigain that you should give somebody. Every single mistake that was made, which a lot of them related to loss of life, became the global Abogane Therapy Safety Guidelines. [00:57:28.19] - Tricia Eastman And so we've already learned from our mistakes here. And so I think it's really important that we understand that there's that aspect, which is really the blood on our hands of if we're not responsible, if we're encouraging people to do this, and we're talking about it in a casual way on Instagram. Like, yeah, microdosing. Well, did you know there was a guy prosecuted this last year, personal trainer, who killed someone And from microdosing in Colorado, the event happened in 2020, but he just got sentenced early 2025. These are examples that we need to look at as a collective that we need. So that's one side of it. And then the other side of it is the reciprocity piece. And the reciprocity piece related to that is, again, the cause and effect. Is A Abogaine clinic talking about doing Abogaine and doing video testimonials, spurring the efforts that are actively being made in Gabon to protect the cultural lineage and to protect the medicine. The reality is every Abogaine clinic is booked out for... I heard the next year, I don't know if that's fact or fiction, but someone told me for a year, because because of all the stuff with all the celebrities that are now talking about it. [00:59:05.20] - Tricia Eastman And then on top of that, you have all these policy, all these different advocacy groups that are talking about it. Essentially, it's not going to be seven... It's going to be, I would say, seven to 10 years before something gets through the FDA. We haven't even done a phase one safety trial for any of the Abigain that's being commercialized. And even if there's some magic that happens within the Trump administration in the next two years that changes the rules to fast track it, it's not going to cut it down probably more than a year. So then you're looking at maybe six years minimum. That whole time, all that strain is being put on Gabon. And so if you're not supporting Gabon, what's happening is it's losing a battle because the movement is gaining momentum, and Gabon cannot keep up with that momentum. It's a tiny country the size of Colorado. So my belief is that anyone who's benefiting from all the hype around Iboga and Abogayne or personally benefited with healing within themselves should be giving back, either to Ancestral Heart, to Blessings of the Forest, to any group that is doing authentic Indigenous-led biocultural stewardship work. [01:00:45.21] - Joe Moore Thanks for that. It's important that we get into some detail here. I wish we had more time to go further on it. [01:00:54.17] - Tricia Eastman I'll do a quick joke. I know. I have a lot. [01:00:57.17] - Joe Moore Yes. Now do Mike Tyson. Kidding. Yeah. So what did we maybe miss that you want to make sure people hear about your book, any biocultural stuff that you want to get out there? You can go for a few more minutes, too, if you have a few things you want to say. [01:01:20.03] - Tricia Eastman I mean, really, thank you so much for this opportunity. Thank you for caring and being so passionate about the context related to Buiti, which I think is so important. I would just say that I've been working with this medicine for... I've known about it for 13 years, and I've been working with it for 11 years, and this is my life. I've devoted my life to this work, me and my husband, both. And there isn't anything greater of a blessing that it has brought in our life, but it also is it's a very saturnian energy, so it brings chaos. It brings the deepest challenges and forces you to face things that you need to face. But also on the other side of the coin, everything that I've devoted and given back in service to this work has exponentially brought blessing in my life. So again, I see the issue with people doing these shortened processes, whether it's in an Abigain clinic where you just don't have the ritualistic sacred aspects of an initiatic context and really the rituals that really help integrate and ground the medicine. But you still have this opportunity to continue to receive the blessings. [01:03:09.23] - Tricia Eastman And I really feel in our current psychedelic movement, we essentially have a Bugatti. These medicines are the most finely-tuned sports car that can do every... Even more than that, more like a spaceship. We have this incredible tool, but we're driving it in first gear. We don't even really know how to operate it. It's like, well, I guess you could say flight of the Navigator, but that was a self-driving thing, and I guess, psychedelics are self-driving. But I feel that we are discounting ourselves so greatly by not looking into our past of how these medicines were used. I really think the biggest piece around that is consulting the genuine lineage carriers like Buiti elders, like Mubu Bwal, who's the head of Maganga Manan Zembe, And giving them a seat at the head of the table, really, because there's so much I know in my tradition, about what we do to bring cardiac safety. And why is it that people aren't dying as much in Gabon as they're dying in Abigan clinics. [01:04:37.28] - Joe Moore Shots fired. All right. I like it. Thank you. Thank you for everything you've done here today, I think harm reduction is incredibly important. Let's stop people dying out there. Let's do some harm reduction language. I actually was able to sweet talk my way into getting a really cool EKG recently, which I thought really great about. If you can speak clinician, you can go a long way sometimes. [01:05:11.20] - Tricia Eastman Yeah. Oh, no, go ahead. Sorry. [01:05:15.17] - Joe Moore No, that's all. That's all. So harm reduction is important. How do we keep people safe? How do we keep healing people? And thank you for all your hard work. [01:05:27.22] - Tricia Eastman Thank you. I really appreciate it. We're all figuring it out. No one's perfect. So I'm not trying to fire any shots at anybody. I'm just like, Guys, please listen. We need to get in right relationship with the medicine. And we need to include these stakeholders. And on the other side of the coin, I just want to add that there's a lot of irresponsible, claimed traditional practitioners that are running retreat centers in Mexico and Costa Rica and other places that are also causing a lot of harm, too. So the medical monitoring is definitely, if you're going to do anything, Because these people don't have the training, the worst thing you could do is not have someone going in blind that doesn't have training and not have had an EKG and all that stuff. But we've got a long way to go, and I'm excited to help support in a productive way, all coming together. And that's what me and Joseph have been devoted to. [01:06:45.02] - Joe Moore Brilliant. Tricia Eastman, thank you so much. Everybody should go check out your book Seeding Consciousness out now. The audiobook's lovely, too. Thank you so much for being here. And until next time. [01:07:00.14] - Tricia Eastman Thank you.
In this episode, we explore brexanolone and zuranolone—the first FDA-approved medications specifically for postpartum depression. How do these neurosteroid-based treatments work differently than traditional antidepressants, and could they offer relief in just days rather than weeks? Faculty: Lauren Osborne, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Understanding Postpartum Mood Disorders: A Comprehensive Guide The Role of Brexanolone and Zuranolone in Postpartum Depression
Dr. Ryan Gober, Medical Science Liaison at Electromedical Products International (EPI). Dr. Gober shares his insights on the science behind Alpha-Stim, its clinical applications for anxiety, insomnia, and pain, and the role of non-invasive brain stimulation in mental health treatment.Electromedical Products International (EPI) is a medical device company specializing in developing neuromodulation technologies including its flagship product, Alpha-Stim. Alpha-Stim is a FDA cleared medical device which utilizes a form of non-invasive electrical stimulation to treat symptoms of anxiety, insomnia, and pain. Ryan Gober is a Medical Science Liaison with EPI's Medical Affairs team responsible for sharing scientific and clinical information related to the Alpha-Stim device. Prior to joining EPI, Ryan completed an NIH research fellowship followed by a PhD in translational neuroscience where he performed research on behavioral health conditions and developed an interest in non-pharmacological options for treating mental health conditions, leading him to join Alpha-Stim. SHOWNOTES:
Welcome to the Planet MicroCap Podcast's Due Diligence series. I'm your host, Robert Kraft. My guest today is Dan Goldberger, CEO of electroCore (NASDAQ: ECOR). electroCore is a commercial-stage neuromodulation company developing a suite of non-invasive vagus nerve stimulation devices—delivering a two-minute therapy session designed to rebalance the autonomic nervous system. Built around its nVNS platform, the company operates across three channels: prescription medical devices for headache and migraine, the fast-growing Truvaga direct-to-consumer wellness brand, and a specialized military and government division built around its ruggedized tac-stim product. Founded in 2006 as a non-invasive alternative to implanted vagus nerve stimulators, electroCore has evolved into a multi-indication business with seven FDA authorizations for headache, serving major customers like the U.S. Department of Veterans Affairs and the UK's National Health Service. I invited Dan to the show to discuss all of this, as well as: How nVNS platform works and the science behind vagus nerve modulation electroCore's evolution from implanted alternatives to multi-channel neuromodulation The prescription business model across the VA, NHS, and managed care Truvaga's growth in the wellness market and why awareness is the primary competitor The tac-stim military program and its role as a meaningful revenue stream Strategic priorities heading into 2026—profitability, capital allocation, and commercial execution Challenges around insurance coverage and overcoming the “chicken and egg” problem The path toward becoming a $150–200 million business and the long-term vision for the platform For more information about electroCore, please visit: https://www.electrocore.com/ This podcast was recorded and is being made available by SNN, Inc. (together with its affiliates and its and their employees, “SNN”) solely for informational purposes. SNN is not providing or undertaking to provide any financial, economic, legal, accounting, tax, or other advice in or by virtue of this podcast. The information, statements, comments, views, and opinions provided in this podcast are general in nature, and such information, statements, comments, views, and opinions, and the viewing of/listening to this podcast are not intended to be and should not be construed as the provision of investment advice by SNN. The information, statements, comments, views, and opinions expressed in this podcast do not constitute and should not be construed as an offer to buy or sell any securities or to make or consider any investment or other course of action. The information, statements, comments, views, and opinions expressed in this podcast (including by guest speakers who are not officers, employees, or agents of SNN) are not necessarily those of SNN and may not be current. Reference to any specific third-party entity, product, service, materials, or content does not constitute an endorsement or recommendation by the SNN. SNN assumes no responsibility or liability for the accuracy or completeness of the content contained in third party materials or on third party sites referenced in this podcast or the compliance with applicable laws of such materials and/or links referenced herein. The views expressed by guest speakers are their own and their appearance on this podcast does not imply an endorsement of them or any entity they represent. SNN does not make any representation or warranty as to the accuracy or completeness of any of the information, statements, comments, views, or opinions contained in this podcast, which may include forward-looking statements where actual results may differ materially. SNN does not undertake any obligation whatsoever to provide any form of update, amendment, change, or correction to any of the information, statements, comments, views or opinions set forth in this podcast. SNN EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR OTHER DAMAGES ARISING OUT OF ANY INDIVIDUAL'S USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE, THIS PODCAST OR THE INFORMATION PRESENTED IN THIS PODCAST. By accessing this podcast, the listener acknowledges that the entire contents and design of this podcast, are the property of SNN, or used by SNN with permission, and are protected under U.S. and international copyright and trademark laws. Except as otherwise provided herein, users of this podcast may save and use information contained in the podcast only for personal or other non-commercial educational purposes. No other use, including without limitation, reproduction, retransmission, or editing of this podcast may be made without the prior written consent of SNN.
Why did the FDA deny sotagliflozin —even with strong data showing heart, kidney, and glucose benefits? In this episode, Dr. Steve Edelman sits down with special guest Stacey Simms to break down the full story behind SGLT inhibitors and their complicated path in type 1 diabetes.Together, they walk through how SGLT inhibitors transformed type 2 diabetes care, why many clinicians believe people with type 1 should have access, and how the risk of DKA shaped the FDA's decision. Dr. Edelman also shares insights on who might benefit, how to reduce risk, and why continuous ketone monitoring could be a game-changer for future approvals.They also touch on the growing discussion around GLP-1 medications in type 1 diabetes, new study results, and what emerging evidence could mean for future treatment options.In this episode: • Sotagliflozin & SGLT Inhibitors in T1D: Why these medications matter and what the latest data shows.• The FDA Denial: Understanding the DKA concerns and why approval remains challenging.• Real-World Experience: How clinicians are using SGLT inhibitors safely today in select patients.• Continuous Ketone Monitoring: Why dual-analyte sensors could unlock safer use in T1D.• GLP-1s in Type 1 Diabetes: What recent research reveals about potential benefits.• Who Might Benefit Most: Kidney protection, heart health, and metabolic improvements.• Looking Ahead: How ongoing studies and patient advocacy could shape future guidelinesLearn more about Diabetes Connections with Stacey Simms: https://diabetes-connections.comVisit TCOYD's Website for more diabetes edutainment for people living with diabetes: tcoyd.org**Tune in for two new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!**Follow our social media channels to empower yourself with the essential areas of diabetes knowledge led by two endocrinologists living with type 1 diabetes: Facebook | Instagram | YouTube ★ Support this podcast ★
In this episode of Data in Biotech, Ross Katz sits down with Callie Celichowski and Isa Kupke from Veloxity Labs to discuss how their CRO leverages speed, precision, and innovation to support drug development. Learn how they use mass spectrometry, cloud-based infrastructure, and hands-on client partnerships to drive rapid, high-quality bioanalytical insights that support everything from preclinical studies to FDA submissions. What you'll learn in this episode: >> Why "speed with purpose" is essential for bioanalytical CROs supporting biotech and pharma clients >> The benefits and challenges of working with peptides and GLP-1 receptor agonists >> How the SCIEX 8600 enhances detection of low-concentration analytes Meet our guests Isa Kupke is Scientist II at Veloxity Labs, where she specializes in mass spectrometry and method development for preclinical and regulated bioanalytical programs. She also co-founded Blyde Botanics, bridging plant-based science and product development. Callie Celichowski is Senior Director of Business Development at Veloxity Labs, with over two decades in the pharmaceutical and CRO space. She's recognized for building strategic client partnerships and driving rapid, data-driven decision-making. About the host Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation. Connect with Our Guest: Sponsor: CorrDyn, a data consultancyConnect with Isa Kupke on LinkedIn Connect with Callie Celichowski on LinkedIn Connect with Us: Follow the podcast for more insightful discussions on the latest in biotech and data science.Subscribe and leave a review if you enjoyed this episode!Connect with Ross Katz on LinkedIn Sponsored by… This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.
The FDA's new Quality Management System Regulation (QMSR), which replaces the 21 CFR Part 820 Quality System Regulation (QSR) and incorporates ISO 13485:2016 by reference, represents a significant harmonization effort in the medical device industry. While viewed by some as a mere streamlining, the change is mandatory, with an effective and fully enforceable date of February 2, 2026. The episode addresses industry complacency and details critical steps manufacturers must take immediately.The episode debunks the myth that familiar quality documents like the DHF, DMR, and DHR are being eliminated. While the specific terms are removed from the regulation's language, their substance is retained and mapped to new, ISO-aligned conceptual requirements: the Device Master Record (DMR) becomes the Medical Device File (MDF), the Design History File (DHF) becomes the Design and Development File (DDP), and the Device History Record (DHR) is captured in the Batch or Lot Record. The host emphasizes that internal documents can retain the old terminology, provided a clear regulatory mapping is established.Crucially, compliance requires more than just an ISO 13485 certificate. Two major philosophical shifts must be addressed: the explicit requirement for integrating lifecycle risk management as the DNA of the entire QMS, and the loss of the audit privilege, which makes internal audit reports, supplier audit reports, and management review records inspectable regulatory evidence. Furthermore, manufacturers must comply with retained, US-specific requirements under the QMSR's prevalence rule, especially concerning mandatory record content (§ 820.35) and specific labeling and packaging controls (§ 820.45).Key Timestamps[0:50] QMSR: The biggest shakeup to US quality requirements since 1996.[2:00] Effective Date: February 2, 2026—the clock is ticking.[2:42] The Goal: Harmonization with ISO 13485:2016 to reduce redundancy for global manufacturers.[3:50] Myth 1 Busted: The FDA is eliminating the DHF, DMR, and DHR (Documentation Dissolution).[5:10] Terminology Shift: DMR > Medical Device File (MDF, ISO 13485 Clause 4.2.3).[6:30] Terminology Shift: DHF > Design and Development File (DDP, ISO 13485 Clause 7.3.10).[7:40] Terminology Shift: DHR > Batch or Lot Record (ISO 13485 Clause 7.5.1).[8:40] The Practical Takeaway: Internal naming is fine, but regulatory mapping is mandatory.[10:30] Critical Shift 1: Risk Management is the DNA of the QMS—Explicitly required across all clauses.[13:00] Critical Shift 2: Loss of the Audit Privilege—Internal audit and management review records are now inspectable.[17:00] Critical Shift 3: Retained FDA Specifications (Prevalence Rule).
Alii! Today, travel medicine specialists Drs. Paul Pottinger & Chris Sanford answer your travel health questions, including:Why should I visit Antarctica?What new-years travel resolutions should I embrace?Probiotics: Will they prevent traveler's diarrhea?Tell me more about the new iPhone earbud interpretation feature (babelfish?)What is going on with pneumonia vaccine approval process at FDA?Tips for avoiding getting scammed when traveling?What is up with a new coronavirus discovered in Brazil?We hope you enjoy this podcast! If so, please follow us on the socials @germ.and.worm, subscribe to our RSS feed and share with your friends! We would so appreciate your rating and review to help us grow our audience. And, please visit our website: germandworm.com where you can find all our content and send us your questions and travel health anecdotes. Or, just send us an email: germandworm@gmail.com.Our Disclaimer: The Germ and Worm Podcast is designed to inform, inspire, and entertain. However, this podcast does NOT establish a doctor-patient relationship, and it should NOT replace your conversation with a qualified healthcare professional. Please see one before your next adventure. The opinions in this podcast are Dr. Sanford's & Dr. Pottinger's alone, and do not necessarily represent the opinions of the University of Washington or UW Medicine.
I just wrapped 6 years of podcasting!!! Episode 350 marks a major milestone for You Are Not Broken: six years, 350 episodes, and a whole lot of growth—personally, professionally, and culturally. In this end-of-year “big winter blowout,” Dr. Kelly Casperson reflects on what 2025 brought, what changed (for better and worse), and why continuing to speak up for women's health still matters more than ever. From world events that shaped the year to personal health wins (yes, including her first colonoscopy), Dr. Casperson shares an honest recap of the moments that mattered. She celebrates big professional milestones—like opening the Casperson Clinic, publishing her second book, winning a podcast award, and helping remove outdated FDA boxed warnings on hormone therapy—while also naming the frustrations, resistance, and misconceptions that persist. This episode also looks ahead: new courses, retreats, sexual health innovations (including a vibrator!), and the continued expansion of education around hormones, sex, and aging. Anchoring it all is a reminder from Theodore Roosevelt's Man in the Arena: progress belongs to those willing to show up, be imperfect, and keep going. Six years and 350 episodes of You Are Not Broken A candid end-of-year reflection on 2025 and the state of the world “Baby's first colonoscopy” and why health screenings matter Travel highlights, including Sydney and the Opera House Publishing a second book and opening the Casperson Clinic Major personal health improvements through strength training and lifestyle changes The book "you are not broken" winning an award and hosting a second annual retreat in Sedona Three separate FDA engagements—and successfully removing outdated boxed warnings on hormone therapy The biggest misconception about FDA changes and how fast (and messy) change can be A frank moment of accountability (and humor) around language and advocacy Updates from the Casperson Clinic, waitlists, and the subscription-based care model Addyi approval for postmenopausal women The future of online education, including upcoming “Summer School” hormone courses Takeaways from male-dominated FDA panels and what they miss What's next: retreats, documentaries, new courses, and new products The top five most-listened-to You Are Not Broken episodes of 2025 Should I Take Hormones? (Ep. 328) How (and Why) to Prescribe Hormones (Ep. 318) GLP-1s with Dr. Salas-Whalen (Ep. 329) Getting Better at Sex – Part One (Ep. 333) Perimenopause Is Real (Ep. 324) New online courses covering testosterone for women, female sex education, GSM, perimenopause, and hormones for longevity A retreat in Whistler (August 2026 — limited spots remaining) The M Factor 2.0: Before the Pause (premieres expected early 2026) A sex education course with Commune launching in 2026 And yes—building a vibrator Dr. Casperson closes with Theodore Roosevelt's Man in the Arena, a reminder that meaningful change doesn't come from critics on the sidelines—it comes from those willing to step into the work, get messy, make mistakes, and keep advocating anyway. If you've been part of this community for one episode or all 350, thank you for being here. This work continues because it matters—and because you do. Listen to the You Are Not Broken podcast on Pinnacle's network to earn FREE CME credit My Website Interested in my sexual health and hormone clinic? Waitlist is open Thanks to our sponsor Midi Women's Health. Designed by midlife experts, delivered by experienced clinicians, covered by insurance.Midi is the first virtual care clinic made exclusively for women 40+. Evidence-based treatments. Personalized midlife care.https://www.joinmidi.com Learn more about your ad choices. Visit podcastchoices.com/adchoices
At-home HPV testing has been approved by the FDA and is being widely marketed as a breakthrough in cervical cancer screening—offering convenience, privacy, and accessibility. But as enthusiasm grows, so do important questions.Can at-home HPV testing truly replace the Pap test? What cancers might be missed? And how should women and clinicians thoughtfully integrate this new option into evidence-based care?In this episode of Sky Women's Health, Dr. Carolyn Moyers talks with Dr. Richard Hopley, pathologist and Director of Clinical Pathology at PathAdvantage, to unpack what the headlines aren't telling you about FDA-approved at-home HPV tests.We discuss why HPV-only testing sounds appealing, what it does well, and where it falls short—especially when used as a replacement for the Pap test.Why This Matters to You* HPV testing alone can miss some cervical cancers—even with a negative result* Certain at-home tests detect transient infections, increasing anxiety and unnecessary procedures* The Pap test still provides critical information HPV tests cannot* Convenience should never come at the cost of missed or delayed diagnosesWhat You'll Learn* Who at-home HPV testing may help—and who it may not* Why many experts still recommend Pap + HPV co-testing* How to interpret HPV results without panic* How to make informed screening decisions that prioritize long-term healthBottom line: At-home HPV testing may expand access, but it does not replace comprehensive gynecologic care. Knowing the limits of new technology helps you protect your health—without relying on headlines alone.https://www.pathadvantage.com/at-home-hpv-testing-promise-or-peril/
Nicola Longo MD, PhD, and Mark Roberts, MDDrs. Longo and Roberts discuss the current status of gene therapies in rare neuromuscular disorders in this eight-part podcast series. This is derived from the symposium that was presented at WORLDSymposium 2025 in San Diego, California on February 4th-7th 2025 and is intended for healthcare professionals only.This podcast includes information about investigational compounds that do not yet have a regulatory approval or authorization for a specific indication. The safety and efficacy of the agents under investigation have not been established and contents of this podcast shall not be used in any manner to directly or indirectly promote or sell the product for unapproved uses.The views, thoughts, and opinions expressed in this presentation belong solely to the author and are subject to change without notice. The contents of this presentation do not constitute an endorsement of any product or indication by Astellas. In this part, Dr. Longo will discuss the current treatment landscape and limitations in lysosomal disorders.Nicola Longo MD, PhDWhat I want to do today, is just place gene replacement therapy within the current landscape of lysosomal storage disorder treatment therapy. Gene therapy obviously has the potential of treating lysosomal disorder to correct the root cause of lysosomal storage disorder. The gene is defective, and what happen is that you can potentially either fix the gene or bypass the lack of the genetic product. But there are already therapies that are existing and are functioning. Obviously, in many cases, the lysosomal disorder is caused by defective production of an enzyme, which is defective.We can either replace the enzyme with enzyme replacement therapy, or provide chaperone for specific mutations that retain the synthesis of the enzyme, that however is not very functional. Another avenue that it is being reported is the utilization of substrate reduction therapy. A substrate accumulates, you prevent the synthesis of the substrate to reduce the accumulation of toxic material. What we know now is that this is not enough to produce many lysosomal disorders. In many cases, the lysosomal disorder result sometime in impairment of intracellular trafficking, and sometime in the function of other organelles.At the end, it results in the activation of the macrophagic system and inflammation. Already we have some therapy acting at this level. The end result of lysosomal storage disorder, there will be cell suffering and cell death, leading to a progression of the disease, and morbidity and mortality. Now, what therapy do we have available already? Obviously, hematopoietic stem cell transplantation has been around for quite some time.It has been the same thing that we do with gene therapy, except that instead of reintroducing the gene of the subject, we place gene of a subject who is not affected of the disease. This therapy has been proven effective in cases of MPS-1 and alpha-mannosidosis. But in many cases this has to be given way before symptoms start to be affected.Enzyme replacement therapy has been around for quite some time, starting with Gaucher disease, and now that it is available for a list of diseases that are there, so it's like Fabry, Gaucher, Pompe, different types of mucopolysaccharidosis, alpha-mannosidosis, acid lipase deficiency, 1 neuronal ceroid lipofuscinosis, and Niemann-Pick type A and B.Obviously the advantage of this therapy, they give back the enzyme that it is defective. But the disadvantage that many time they cannot enter specialized areas such as the brain. There is already the second generation of enzyme replacement therapy that it is available. With this second generation, some of the newer drugs are more effective in terms of cellular uptake, or in terms of having a prolonged half-life and prolonged activity.Then there are pharmacological chaperone therapy, and the one which is FDA approved is migalastat for Fabry disease, under study is ambroxol for Gaucher disease. The disadvantage of this therapy that only a selected number of mutations respond to this therapy.Substrate reduction therapy has been introduced for Gaucher disease many years ago with miglustat, and it was followed by eliglustat. Both of them are effective, and some of them more effective than other, simply because of the fewer side effects of eliglustat as compared to miglustat. But at the same time, eliglustat does not pass the blood brain barrier.Finally, the newer agents that are already administered, N-acetyl-L-leucine and arimoclomol, both approved for Niemann-Pick type C, they act more on the downstream effect of the lysosomal storage disorder, either by stabilizing neuronal cell activity or by reducing the inflammation that is present in the brain.In the next part, Dr. Longo will discuss gene replacement therapy in lysosomal disorders.
On this episode of Vitality Radio, Jared breaks down amino acids—what they are, how they work in the body, and how to supplement them strategically for muscle health, recovery, fasting, metabolism, and healthy aging. He explains the difference between essential amino acids, branched-chain amino acids (BCAAs), collagen, protein powders, and whole-food protein, and clarifies when each one makes the most sense. Jared also walks through practical use cases, including workout performance, muscle preservation during fasting, age-related muscle loss, and supporting lean mass during calorie restriction—without hype! If protein goals, collagen, amino acids, or fasting protocols have been confusing, this episode delivers clear, practical guidance you can actually use.Products:Vitality Nutrition Essential AminosRebuild+ Functional Bone Broth Protein Additional Information:#573: Protein Showdown: Whey, Collagen, Bone Broth, Plant Based, and Beyond!Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.
Broadcast from KSQD, Santa Cruz on 12-18-2025: Dr. Dawn opens by examining how market competition is actually working in the weight loss drug sector. Novo Nordisk's Ozempic and Wegovy compete against Eli Lilly's Monjaro and ZepBound, with prices dropping nearly 50% as companies launch direct-to-consumer websites. The main barriers remain needles and refrigeration, driving development of oral versions. Novo's Wegovy pill awaits FDA approval for early 2026 launch at $150 monthly. Next-generation drugs show remarkable results: Eli's retatrutide causes 24% weight loss in 48 weeks, while Novo's Cagrisema combines semaglutide with amylin to reduce muscle loss. Pfizer paid $10 billion for Metsera's once-monthly drug despite significant side effects. A quick fiber tip suggests adding plain psyllium to morning coffee for cardiovascular and microbiome benefits. Start with half a teaspoon and work up to two teaspoons (10 grams) over several weeks to avoid gas. The prebiotic fiber improves glucose tolerance and may reduce cancer risk. UC San Diego scientists discovered why cancers mutate so rapidly despite being eukaryotic cells with protected chromosomes. The answer is chromothripsis, a catastrophic event where the enzyme N4BP2 literally explodes chromosomes into fragments. These reassemble incorrectly, generating dozens to hundreds of mutations simultaneously and creating circular DNA fragments carrying cancer-promoting genes. One in four cancers show evidence of this mechanism, with all osteosarcomas and many brain cancers displaying it. This explains why the most aggressive cancers resist treatment. Research from 2013 shows any glucocorticoid use significantly increases venous thromboembolism risk, with threefold increases during the first month of use. The risk applies to new and recurrent clots, affecting both oral and inhaled steroids, though IV poses highest risk and topical the lowest. Joint injections fall somewhere between inhaled and oral. Anyone with prior blood clots should avoid steroids except for life-threatening situations like severe asthma attacks requiring ventilation. A meta-analysis of 20 randomized controlled trials shows creatine supplementation helps older adults (48-84) maintain muscle mass when combined with weight training two to three times weekly. The supplement provides no benefit without exercise. Recommended dosing starts at 2 grams and works up to 5 grams daily. Vegans benefit most since they consume little meat or fish. Important caveat: creatine throws off standard kidney function tests (creatinine), so users should request cystatin C testing instead for accurate renal health assessment. A new JAMA study suggesting risk-based mammogram screening is fatally flawed. First, researchers offered chemopreventative drugs like tamoxifen only to the high-risk group, contaminating the study design. Second, the demographics skewed heavily toward white college-educated women, missing the reality that Black women face twice the risk of aggressive breast cancer with 40% higher mortality. Third, wild-type humans failed to follow instructions—low-risk women continued getting annual mammograms anyway while high-risk women skipped recommended extra screenings. The conclusion of "non-inferior" outcomes is meaningless given poor adherence. Stick with annual mammograms, and consider alternating with MRIs for high-risk women. The EAT-Lancet report condemns red meat based purely on observational data showing correlations with heart disease, cancer, and mortality. But people who eat lots of red meat differ dramatically from low consumers: they weigh more, smoke more, exercise less, and eat less fiber. Studies can't control for sleep quality, depression, or screen time. Notably, heavy meat eaters also die more in accidents, suggesting a risk-taking lifestyle phenotype. The inflammatory marker TMAO is higher in meat eaters, but starch is also pro-inflammatory. Eating red meat instead of instant ramen might improve health. A balanced diet with limited amounts beats epidemiology-based blanket statements. Dr. Dawn grades Dr. Oz's performance as CMS administrator. Starting at minus one for zero relevant experience, he earns plus two for promoting diet, exercise, and gut health on his show. He studied intensively after nomination, calling all four previous CMS directors repeatedly and surrounding himself with experienced staff (plus one). He finalized Medicare rules favoring prevention over surgery and earned bipartisan praise as "a real scientist, not radical" (plus one). He divested healthcare holdings but kept some blind trust interests (minus 0.5). He's developing a CMS app and partnering with Google on a digital health ecosystem (plus one), but supports ending ACA subsidies that will raise premiums for millions (minus one). He correctly promoted COVID vaccines and contradicted Trump's Tylenol-autism claims (plus one). Final score: 3.5 out of 5 possible points, the only positive score for any Trump health administrator.
What if it was a beautiful ginger bush. For simple, online access to personalized and affordable care for Hair Loss, ED, Weight Loss, and more, visit Hims.com/SUPERMEGA Individual results may vary. Based on studies of topical and oral minoxidil and finasteride. Featured products include compounded drug products, which the FDA does not approve or verify for safety, effectiveness, or quality. Prescription required. See website for full details, restrictions, and important safety information. Follow Matt: @matthwatson Follow Ryan: @elirymagee Follow the show: @supermegashow Learn more about your ad choices. Visit podcastchoices.com/adchoices
Dan Miller unpacks how Republican policy and ideology are converging around harm rather than governance. He begins with healthcare, breaking down how congressional action allowed Affordable Care Act subsidies to lapse and what that means for millions of Americans who rely on them. Rather than offering alternatives, the GOP continues to frame healthcare through an ideological lens that treats public support as illegitimate, even when the human cost is clear. From there, Dan traces the familiar shift from policy failure to moral panic, focusing on the escalating attacks on trans youth. He examines the House passage of Marjorie Taylor Greene's Protect Children's Innocence Act, the Trump administration's push to ban gender affirming care for minors, and recent FDA actions targeting breast binders. Dan connects these moves to a broader right wing strategy that defines itself through opposition to marginalized groups, warning that restrictions justified in the name of protecting children and morality often pave the way for wider government overreach. He closes by looking at Pete Hegseth's influence inside the military and the dangers of folding Christian nationalism into institutions meant to serve a pluralistic society. Subscribe for $5.99 a month to get bonus content most Mondays, bonus episodes every month, ad-free listening, access to the entire 1000+ episode archive, Discord access, and more: https://axismundi.supercast.com/ Linktree: https://linktr.ee/StraightWhiteJC Order Brad's book: https://bookshop.org/a/95982/9781506482163 Subscribe to Teología Sin Vergüenza Subscribe to American Exceptionalism Learn more about your ad choices. Visit megaphone.fm/adchoices
No wonder so many FDA members pushed back against the Trump administration's proposal to test vaccines more thoroughly before putting them on the market: They were making millions off big pharma. The Trump administration also moves to ban all hospitals from doing sex change operations of children. Listen to the pearl clutching. Good News is about good people becoming good customers and even better neighbors.
Up first, Inspirogene-by-McKesson with Joe DePinto InspiroGene" is a dedicated business unit launched by McKesson in October 2024, focused solely on supporting the commercialization of cell and gene therapies (CGTs). It leverages McKesson's expertise in supply chain, logistics, and specialty pharmacy to help manufacturers, payers, and providers navigate the complex CGT landscape. https://www.mckesson.com/business-solutions/our-businesses/inspirogene-by-mckesson/ Our featured interview: Sponsored by MatchRX The TrumpRx Playbook for Independent Pharmacies CEO of MatchRx Johny Kello co-hosts with Todd Eury featuring our guest speaker, Dae Lee, Pharm.D., Esq., CPBS. Dae is a pharmacist-attorney and a Shareholder in the FDA & Biotechnology practice at Buchanan Ingersoll & Rooney. What makes Dae especially valuable for this conversation is that he's not just reading policy from 30,000 feet — he represents pharmacies every day in high-stakes fights with PBMs, from audits and reimbursement disputes to network suspensions and terminations. So, when we talk about TrumpRx — how it works, what it could break, and what independents should do next — Dae can translate the legal and contracting reality into real-world consequences behind the counter. Connect with MatchRX: MatchRX.com Special Message from Greg Reybold with APCI, update of the "Pharmacists Fight Back Act" Connect with Greg: https://www.apcinet.com/ Next, we talk with Dr. Jessica Daley PharmD Fractional Supply Chain and Operations Executive, with Pharma Logistics, we dicuss drug shortages and strategies for 2026. Connect with Jessica: https://www.linkedin.com/in/jessicaldaley/ Last interview, a suprise message from International Pharmacy 50 Pharmacist & Author Katrina Azer, announcing her new book https://www.katrinaazer.com/#books The TrumpRx Playbook for Independent Pharmacies - with MatchRX | TWIRx
Send us a textAbout Dr. Moshe Mendelson:Dr. Mendelson has been a clinical investigator for FDA contact lens studies. He is currently an Adjunct Professor for the New England College of Optometry, and has taught students from various colleges throughout his career. Dr. Mendelson is a leading optometrist in the field of Orthokeratology/CRT overseeing one of the busiest Orthokeratology/CRT practices in the nation. He has devoted his practice to this field. Over the last 30 yearsDr. Mendelson has fit thousands of patients with Orthokeratology/CRT contacts and achieved the designation of F.I.A.O., Fellow of the International Academy of Orthokeratology. Dr. Mendelson is one of only a few doctors to obtain this title.He is a member of the American Optometric Association as well as the California Optometric Association. Dr. Mendelson is passionate about his care and works with local schools to provide eye care to underprivileged children.---If you're considering or have ever considered getting a virtual team member for your practice check out hiredteem.com, mention The Myopia Podcast when signing up for a $250 dollar discount off of your first month's teem member.https://hireteem.com/myopia-podcast/
*Mariah Carey voice* IT'S TIIIIIIIIME… For our annual year-in-review! HOE-HOE-HOLY shit, Buzzkillianas. 2025 was a hellacious year in Abortlandia, so you already know the Feminist Buzzkills are re-hashing, re-roasting, re-raging, and even re-celebrating over what went down this year in regards to all tings repro-related. Lizz and Moji took a little sleigh ride down memory lane, made their lists checking them twice, and figured out what stories were the naughtiest, the nicest and the bizarre AF-est! From a certain brainworm host thinking the nation guzzles abortion water, to exposing the hypocrisy of an anti-abobo Bible humper who just got caught using AI to make something so disgusting we'd get banned if we told you—so we're spilling anyway. And YES, there actually were some abobo wins this year too! So, buckle up for our favorite end of year tradition: unpacking the year's top-tier triumphs and bottom-of-the-barrel, bargain-bin bullshit of abortion news. Times are heavy, but knowledge is power, y'all. We gotchu. OPERATION SAVE ABORTION: Check out our NEW Operation Save Abortion workshop, recorded a live from Netroots Nation 2025 that'll train you in coming for anti-abobo lawmakers, spotting and fighting against fake clinics, AND gears you up on how to help someone in a banned state access abortion. You can still join the 10,000+ womb warriors fighting the patriarchy by listening to past Operation Save Abortion trainings by clicking HERE for episodes, your toolkit, marching orders, and more. HOSTS:Lizz Winstead @LizzWinsteadMoji Alawode-El @Mojilocks WORST NEWS OF 2025:Lizz: RFK Jr. AppointmentMoji: Tierra Walker BEST NEWS OF 2025:Lizz: My Voice My Choice WinMoji: Generic Abortion Pill Approval WEIRDEST NEWS OF 2025:Lizz: Catch KitMoji: Christian Nationalist Pastor's Son's AI Toddler Porn EPISODE LINKS:WATCH: Full RFK Jr. VideoKennedy Says FDA Is Reviewing Safety of Abortion Pill MifepristoneUS FDA Has Delayed Abortion Pill Safety Study, Bloomberg News ReportsLeaders of 2 Major Anti-Abortion Groups Call for Trump's FDA Chief to Be FiredThe Worst Ways RFK Jr. Has Harmed Public Health This YearWATCH: Ashley Flowers Exposing Jonathan PeternelJunk Science Study on MifepristoneMaternal Mortality in the United States After Abortion BansTierra Walker's Aunt's StatementMy Voice My Choice on Instagram: SAFE ABORTION IN EUROPE IS COMINGMy Voice My ChoiceADOPT-A-CLINIC: The Women's Health Center of MarylandThe Women's Health Center of MarylandTICKETS: Dec 31 - The Lizz Winstead Files at The Parkway TheaterOperation Save AbortionExpose Fake ClinicsBUY AAF MERCH!EMAIL your abobo questions to The Feminist BuzzkillsAAF's Abortion-Themed Rage Playlist FOLLOW US:Listen to us ~ FBK Podcast Instagram ~ @AbortionFrontTwitter ~ @AbortionFrontTikTok ~ @AbortionFrontFacebook ~ @AbortionFrontYouTube ~ @AbortionAccessFrontTALK TO THE CHARLEY BOT FOR ABOBO OPTIONS & RESOURCES HERE!PATREON HERE! Support our work, get exclusive merch and more! DONATE TO AAF HERE!ACTIVIST CALENDAR HERE!VOLUNTEER WITH US HERE!ADOPT-A-CLINIC HERE!EXPOSE FAKE CLINICS HERE!GET ABOBO PILLS FROM PLAN C PILLS HERE!When BS is poppin', we pop off! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
As 2025 closes, biopharma and healthcare are learning to live on shifting ground. In this special year-end episode of "The Top Line," Fierce reporters take stock of a year defined by federal research cuts, vaccine policy fights and leadership churn at the FDA, then push the conversation forward into the questions that will shape 2026. The through line is that uncertainty has become an operating environment, and the industry is recalibrating in real time. Fierce Biotech’s Gabrielle Masson, joined by Darren Incorvia, traces how funding decisions can narrow the pipeline years before the consequences are visible. Fierce Pharma’s Fraiser Kansteiner sits down with Angus Liu and Eric Sagonowsky to unpack the new center of gravity inside federal agencies, where vaccine recommendations, review norms and new FDA pilots are colliding with questions about capacity and outside influence. From there, Ben Adams and James Waldron bring the lens to Europe, where Jefferies in London captured a cautiously optimistic market still wrestling with tariffs, pricing pressure and investment hesitation. The episode closes with Fierce Healthcare’s Heather Landi and Paige Minemyer sharing their outlook on 2026, from the fight over ACA subsidies and Medicaid headwinds to the next phase of AI adoption, where the promise is real but the payoff may be slower, messier and more uneven than the hype suggests. To learn more about the topics in this episode: 'Unprecedented turmoil' engulfing FDA threatens public health: mRNA coalition speaks out FDA names Tracy Beth Høeg, fresh from vaccine safety probe, as acting head of drug center A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation NIH grant cuts have disrupted hundreds of clinical trials, study finds 'Alternative history' of the NIH shows how a 40% budget cut may thwart new medicines House passes healthcare affordability bill without subsidy extension AMA: A look at concentration in commercial insurance, MA markets 2025 Outlook: Hospital finances show signs of stability, but rising costs will be a major headwind See omnystudio.com/listener for privacy information.
In this episode, we sit down with Dr. Jean Bennett, Professor Emeritus of Ophthalmology at Penn Medicine and a true pioneer in gene therapy research. Dr. Bennett led the team that developed the first FDA-approved gene therapy to treat inherited blindness, transforming the lives of patients with retinitis pigmentosa and other retinal diseases. Her groundbreaking work spans over three decades and has opened doors for gene therapy applications far beyond ophthalmology. Dr. Bennett shares her remarkable journey from a curious child in New Haven, Connecticut—who chose seeds over candy at age four—to becoming a world-renowned scientist. She opens up about the challenges she faced as a woman in science, including being advised to leave her field entirely when seeking tenure at Penn. With candor and humor, she discusses how mentorship from previous Girl Power Gurus guest, Dr. Virginia Lee, helped her persevere, the emotional eureka moment when blind dogs first regained their sight, and what it felt like to witness blind children see for the first time. Dr. Bennett also offers invaluable advice for young women pursuing STEM careers, emphasizing the importance of finding work you love, building collaborative teams, and never giving up on your dreams despite the obstacles. This is a must-listen for anyone interested in science, medicine, or the power of determination.
R-Soul: Reclaiming the Soul of Reproductive Health, Rights, and Justice
2025 brought what feels like several years' worth of experiences: a new federal political administration, drastic worsening of life for families in the U.S. due to Project 2025, and a deepening struggle for reproductive freedom in Ohio and beyond. Kelley Fox and Rev. Terry Williams look back on the year from both community and organizational perspectives, exploring how the seemingly darkest of times can be fruitful ground for growth, strategic development, and expectant preparation. Kelley and Terry highlight the amazing things that happened at Faith Choice Ohio in the past year including launching our on-demand Faith for Repro Training Center, developing 10 new mini-zine offerings, organizing across regions with various clergy & congregations, and much more! Links to discussed content: Presidential pardons for anti-abortion criminals: https://apnews.com/article/abortion-trump-executive-order-pardon-817774b21d32a4edf6d39ee43cbc18f4 Project 2025 targets repro advocates, transgender rights, and more: https://19thnews.org/2025/12/project-2025-heritage-foundation-progress/ DOGE undermines AIDS prevention and health policy: https://thehill.com/policy/healthcare/5263506-former-trump-official-doge-cuts-hiv-aids-epidemic/ FDA approves Mifepristone generic as safe and effective: www.pbs.org/newshour/health/fda-approves-another-generic-abortion-pill-prompting-conservativ... Faith for Repro Training Center: www.faithchoiceohio.org/trainings PRIDE 2025 with Faith Choice Ohio: www.faithchoiceohio.org/pride Faith4Repro Store: www.faithchoiceohio.org/store Minister in Residence, Constance M. Dunlap: www.faithchoiceohio.org/blog/justice-as-an-invitation-to-transformation 2025 Intern, Karina Streeter: www.faithchoiceohio.org/blog/the-power-of-youth-led-organizing FREE Mini-Zines for distribution: www.faithchoiceohio.org/zines Get plugged in with Ohio Clergy for Choice: www.faithchoiceohio.org/clergy-for-choice Video Library at Faith Choice Ohio: www.faithchoiceohio.org/videos Give Faithfully for Reproductive Justice: www.faithchoiceohio.org/blog/give-faithfully-for-reproductive-justice Music by Korbin Jones
Pioneering Women's Health: From International Aid to Hormone Therapy AdvocacyIn this episode of Women Making Moves, host Amy Pons converses with Elizabeth Kelly, a seasoned nurse practitioner passionate about holistic healthcare. Elizabeth shares her journey from working in intensive care units in Chicago to providing international aid and her deep commitment to improving access to mental health care in underserved populations. She highlights the critical importance of hormone replacement therapy (HRT) for women and discusses the recent FDA removal of the black box warning on HRT medications. Elizabeth also addresses the alarming Department of Education decision to downgrade nursing and other female-dominated professions' status, potentially reducing access to federal funding and impacting women's upward mobility in these fields. The episode offers insights into the systemic challenges women face in healthcare and the importance of interdisciplinary and compassionate approaches to patient care.00:00 Introduction and Guest Background00:20 Elizabeth's Journey in Healthcare01:05 Mental Health Challenges and Holistic Care03:24 Personal Stories and Healthcare Gaps05:06 The Importance of Holistic Approaches06:00 Generational Trauma and Mental Health14:09 Hormone Replacement Therapy (HRT) Insights20:39 Recognizing Women's Health Issues22:07 Challenges in Prescribing HRT23:07 Historical Neglect of Women's Health23:57 Black Box Warnings and Opiate Crisis25:26 Impact of Education Policy Changes27:32 Financial Barriers in Female-Dominated Professions36:54 Encouragement for Aspiring Nurses39:14 Final Thoughts and Contact InformationFollow and support Elizabeth on Instagram and Facebook @stayinyourcortex and visit her at Ardent Counseling Center Oak Brook https://ardentcenter.com/team-member/elizabeth-kelly/Thank you for tuning in to Women Making Moves, be sure to rate and subscribe to the show on your favorite podcast platform and follow along on Instagram and Bluesky. Visit Amy at Unlock the Magic, and follow on Instagram and LinkedIn.Women Making Moves is for personal use only and general information purposes, the show host cannot guarantee the accuracy of any statements from guests or the sufficiency of the information. This show and host is not liable for any personal actions taken.
In this episode, Dr. Shawn Tassone discusses the new FDA approval of a prescription called Addyi, aimed at treating Hypoactive Sexual Desire Disorder (HSDD) in women. He explains the differences between male and female sexual responses, the limitations of Addyi, and the marketing strategies that may mislead women about its effectiveness. Dr. Tassone emphasizes the importance of addressing underlying issues related to libido and the potential risks associated with Addyi, urging listeners to have open conversations with their partners and healthcare providers about sexual health. Episode Highlights: The history of Addyi How Addyi is marketed as a solution for women's sexual desire issues How the female sexual response is more complex than the male sexual response Factors that influence female libido beyond hormonal levels How Addyi affects serotonin levels similarly to antidepressants Why the marketing of Addyi may mislead women Results of clinical trials with Addyi What women should know about taking Addyi with other medications Why open communication with partners is crucial for women's sexual health Reasons underlying issues should be addressed before considering Addyi Episode Resources: Dr. Tassone's Free Women's Health Journal Club | Dr. T's Evidence Edit Dr. Shawn Tassone's Practice | Tassone Advanced Gynecology Dr. Shawn Tassone's Book | The Hormone Balance Bible Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormonal Archetype Quiz Medical Disclaimer This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.
Dave Rubin of "The Rubin Report" talks to Rep. Nancy Mace about why she thinks the GOP will suffer massive losses in the midterm elections; Washington dysfunction and why Congress struggles to pass legislation; why only a tiny fraction of House bills become law; how Senate gridlock is blocking President Trump's agenda; why Republicans risk losing the House without a tougher, Pelosi-style strategy; South Carolina's rapid growth and conservative values; and much more. Check out the NEW RUBIN REPORT MERCH here: https://daverubin.store/ ---------- Today's Sponsors: Juvent - Stop joint pain and stiffness with the Juvent Micro-Impact Platform. In the US, the Juvent device is considered investigational for the treatment of osteoporosis or improvement/maintenance of bone mineral density. Our claims have not been reviewed or cleared by the FDA to treat any disease or condition. The JUVENT® Micro-Impact Platform® is registered as a Class I medical device for exercise and rehabilitation." Go to http://Juvent.com/RUBIN and use the code RUBIN to save $300 on your own Juvent.
This episode is sponsored by Ageless Forever Anti-Aging and Wellness Center LightSpeed VT: https://www.lightspeedvt.com/ Dropping Bombs Podcast: https://www.droppingbombs.com/ In this must-watch Dropping Bombs episode, board-certified emergency physician, military veteran, Las Vegas SWAT tactical physician, and medical director of Ageless Forever Anti-Aging and Wellness Center Dr. John Pierce exposes Western medicine's broken system. He reveals how FDA conflicts of interest restrict proven therapies (like banned peptides) while toxic food remains legal, preventing individuals from achieving optimal health. Hear raw insights on stress, sleep, and the truth about anti-aging medicine that conventional doctors won't tell you. Dr. Pierce delivers actionable strategies: integrative wellness, personalized lab work, and hormone optimization protocols elite performers use. Ready to escape cookie-cutter guidelines and unlock the anti-aging secrets Big Pharma doesn't want you to know? This conversation exposes it all.
Depo-Provera was approved in 1992 by U.S. regulators. About 1 in 4 sexually active women in the United States have used the shot at some point, according to the U.S. Centers for Disease Control and Prevention (CDC). Meningiomas are common intracranial tumors with a female predominance. In fact, they are the most common primary brain tumor in women, with an incidence of approximately 12.76 per 100,000 in the general female population. The vast majority of these tumors are benign (World Health Organization [WHO] grade 1) while 15% to 20% of these tumors can behave atypically (WHO grade 2) and rarely, in 1% to 2% of cases, these tumors can be malignant (WHO grade 3). We covered the relationship between Depo-Provera, as a contraceptive agent, and brain meningiomas back in March 2024. With the increase in data, the ACOG released a patient centered counseling tool titled, “Counseling Patients on Birth Control Injection and Meningioma”. The most recent update on this story comes from the FDA, which has granted a medication label change to Depo-Provera (Pfizer) warning of this association. Even though association does not prove causation, the association between depo and meningiomas seems strong (with new data from the US). Does this warning extend to other progestins? Listen in for details. 1. https://podcasts.apple.com/us/podcast/dr-chapas-obgyn-clinical-pearls/id1412385746?i=10006508795722. ACOG's “Counseling Patients on Birth Control Injection and Meningioma” 3. https://www.statnews.com/pharmalot/2025/12/17/fda-pfizer-contraception-cancer-preemption-depoprovera/4. Xiao T, Kumar P, Lobbous M, et al. Depot Medroxyprogesterone Acetate and Risk of Meningioma in the US. JAMA Neurology. 2025;82(11):1094-1102. doi:10.1001/jamaneurol.2025.3011.5. de Dios E, Näslund O, Choudhry M, et al.Prevalence and Symptoms of Incidental Meningiomas: A Population-Based Study.Acta Neurochirurgica. 2025;167(1):98. doi:10.1007/s00701-025-06506-7.6. Schaff LR, Mellinghoff IK.Glioblastoma and Other Primary Brain Malignancies in Adults: A Review. JAMA. 2023;329(7):574-587. doi:10.1001/jama.2023.0023.7. BMJ 2024; 384 doi: https://doi.org/10.1136/bmj-2023-078078 (Published 27 March 2024) Cite this as: BMJ 2024;384:e078078
What if the future of healthcare isn't about taking more medications—but about understanding why your body is out of balance in the first place? That's the eye-opening conversation at the heart of this episode of Late Night Health, featuring Dr. Nayan Patel, a clinical pharmacist, educator, and founder of Central Drugs Compounding Pharmacy.Dr. Patel isn't your typical pharmacist. With decades of experience working directly with physicians across the country, he specializes in customized, patient-specific care—from compounded medications to nutrition, supplementation, lifestyle changes, and advanced wellness modalities. In this candid and wide-ranging interview, he explains why “one-size-fits-all” medicine often falls short and how truly personalized treatment plans can help patients take control of their health.Listeners will learn what a compounding pharmacy really does—and why it plays a critical role when commercially available drugs don't meet a patient's unique needs. Dr. Patel also dives into the complex and often controversial world of supplements, prescription medications, and the overuse of both in modern healthcare. He doesn't shy away from discussing Big Pharma, pricing frustrations, and why many older, effective medications quietly disappear from the marketplace.One of the most compelling parts of the interview centers on hormone replacement therapy (HRT). Dr. Patel breaks down recent FDA changes, explains why hormones themselves aren't the enemy, and reveals why balance—not dosage—is the key to safety and effectiveness. He also introduces a powerful insight many patients overlook: stress management and cortisol regulation often matter far more than sex hormones alone.Perhaps most inspiring is Dr. Patel's philosophy that patients should become the CEO of their own health. Instead of simply managing symptoms for life, he challenges both doctors and patients to address root causes—sometimes with fewer prescriptions and smarter lifestyle choices.This is a must-listen episode for anyone navigating chronic health issues, questioning conventional approaches, or seeking a smarter, more individualized path to wellness. Don't miss the full interview—it may change how you think about healthcare forever. Become a supporter of this podcast: https://www.spreaker.com/podcast/late-night-health-radio--2804369/support.
Send Zorba a message!Zorba talks about the FDA considering adding a black box warning to Covid vaccines. And he lays out a plan for taking civic action with your elected representatives.Find your elected representatives here:https://www.congress.gov/members(Recorded December 16, 2025)Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!
“People are not looking for a perfect, polished answer. They're looking for a human to speak to them like a human,” says Jessica Malaty Rivera, an infectious disease epidemiologist and one of the most trusted science communicators in the U.S. to emerge from the COVID-19 pandemic. That philosophy explains her relatable, judgement-free approach to communications which aims to make science more human, more accessible and less institutional. In this wide-ranging Raise the Line discussion, host Lindsey Smith taps Rivera's expertise on how to elevate science understanding, build public trust, and equip people to recognize disinformation. She is also keen to help people understand the nuances of misinformation -- which she is careful to define – and the emotional drivers behind it in order to contain the “infodemics” that complicate battling epidemics and other public health threats. It's a thoughtful call to educate the general public about the science of information as well as the science behind medicine. Tune in for Rivera's take on the promise and peril of AI-generated content, why clinicians should see communication as part of their professional responsibility, and how to prepare children to navigate an increasingly complex information ecosystem.Mentioned in this episode:de Beaumont Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast
Today, Ali is talking to René Byrd, a British-born singer, songwriter, and media personality known for her powerful voice, soulful pop and R&B style, and her bold, heartfelt storytelling. On this episode, she tells her deeply personal egg freezing, infertility and family building journey, including giving birth to her son via IVF at age 48. Rene talks about the retreat that changed her life for the better, meeting her future husband in a bar (and how she knew she would build her family with him), and facing backlash when she became a mom in her late forties. She also shares the lessons she's learned regarding advocacy, fertility awareness and maternal wellbeing. Follow on IG: @Renebyrdofficial @Renebyrdofficialglobal EPISODE SPONSORS: THE WORK OF ART BOOK SERIESAli's Children's Book Series about IVF, IUI and Family Building Through Assisted Reproductive Technology https://www.infertileafgroup.com/booksThe latest book in the Work of ART series, “You Are a Work of ART," is for every kiddo born through ART -- and the people who love them.Order "Work of ART," "Beautiful Bird" and "You Are a Work of ART," now at https://www.infertileafgroup.com/booksFERTILITY RALLYIG: @fertilityrallywww.fertilityrally.comNo one should go through infertility alone. Join the Worst Club with the Best Members at fertilityrally.com. We offer 5 to 6 support groups per week, three private Facebook groups, tons of curated IRL and virtual events, and an entire community of more than 500 women available to support you, no matter where you are in your journey.Join today at link in bio on IG @fertilityrally or at www.fertilityrally.com/membershipPHERDALIG: @pherdal_sciencePherDal is the world's first and only FDA-cleared, sterile, at-home insemination kit designed to help people build their families in the comfort of home. Created by parents who've been there, PherDal is safe, simple, and affordable—putting more options in your hands as you grow your family. Explore at PherDal.com.Go to PherDal.com today and use code INFERTILEAF for $10 off.Support this podcast at — https://redcircle.com/infertile-af-infertility-and-modern-family-building-through-art/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacySupport this podcast at — https://redcircle.com/infertile-af-infertility-and-modern-family-building-through-art/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Howie Kurtz on President Trump's controversial comments about the tragic death of Rob Reiner and his wife, the passing of Norman Podhoretz, a prominent neoconservative thinker and writer, and the FDA's expanded approval of a drug aimed at boosting female libido. Follow Howie on Twitter: @HowardKurtz For more #MediaBuzz click here Learn more about your ad choices. Visit podcastchoices.com/adchoices
One drunken afternoon Michelle's girlfriend confessed to a murder. The circumstances surrounding the killing were darker than she could imagine, and it's turned her life upside down. DRIP DROP Get 20% off your first order: dripdrop.com and use promo code secret. HERS Visit forhers.com/SECRET for your personalized weight loss treatment options. Hers Weight Loss by Hers is not available everywhere. Compounded products are not approved or reviewed for safety, effectiveness, or quality by the FDA. Prescription required. See website for full details, important safety information, and restrictions. Actual price depends on product and plan purchased. PICTURES See pictures from Michelle's story.They are waiting for you on Threads, Facebook, Instagram and X. Handle: @secretroompod. YOUTUBE You can listen to The Secret Room now on YouTube! THE SECRET ROOM | UNLOCKED Host: Susie Lark. The Secret Room | Unlocked is yours when you support your favorite indie podcast that could with a membership at patreon.com/secretroom, Apple Podcasts or Spotify. There's a free trial! ALL OUR SPONSORS See all our sponsors past and present, and their offers, many of which are still valid: secretroompodcast.com/codes FACEBOOK DISCUSSION GROUPThere's even more fun at The Secret Room Podcast Facebook Discussion Page! Just ask to join, all are welcome. :) YOUR SECRET Click "Share a Secret" at secretroompod.com! PODCAST TEAM Producer: Susie Lark. Story Development: Luna Patel. Music and Theme: Breakmaster Cylinder. LISTENER SURVEY Take our Listener Survey at SecretRoomPod.com!
Kratom: Legal high or dangerous addiction? Nick Pell breaks down this gas station opioid alternative here on Skeptical Sunday!Welcome to Skeptical Sunday, a special edition of The Jordan Harbinger Show where Jordan and a guest break down a topic that you may have never thought about, open things up, and debunk common misconceptions. This time around, we're joined by writer and researcher Nick Pell!Full show notes and resources can be found here: jordanharbinger.com/1257On This Week's Skeptical Sunday:Kratom is coffee's rebel cousin with a split personality. This plant from the coffee family produces contradictory effects based on dose: low amounts deliver stimulant energy, while high doses act as a mild opioid mimicking weak Vicodin.Daily high-dose kratom use (10+ grams) creates opioid-like addiction. Withdrawal symptoms mirror opioid withdrawal but milder: anxiety, muscle aches, insomnia, and flu-like symptoms lasting a week or more with minimal medical support.Kratom exists in regulatory limbo due to supplement laws. DSHEA (1994) treats it as food, not a drug, requiring no FDA approval. This creates quality control nightmares with zero potency or purity standards across products.Scientific research on kratom is scandalously sparse. Most knowledge comes from Reddit posts and YouTube videos rather than rigorous studies, leaving a potential opioid-replacement tool completely unstudied despite addiction crisis.Informed decision-making beats fear or hype. Research dosage, sources, and risks before trying any substance. Understanding how kratom works empowers you to make smarter choices about whether it fits your needs or should be avoided entirely.Connect with Jordan on Twitter, Instagram, and YouTube. If you have something you'd like us to tackle here on Skeptical Sunday, drop Jordan a line at jordan@jordanharbinger.com and let him know!And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors:Superpower Health Inc: $49 gift box with gifted membership: superpower.com/gift and tell 'em we sent youApretude: Learn more: Apretude.com or call 1-888-240-0340Jaspr: Visit jaspr.co and use code JORDAN for $400 offHomes.com: Find your home: homes.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
© 2020-2025 Ivy Podcast Discovery LLC
